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Abstract:
Our lab identified the tandem BRCT domains of PTIP function as a DNA damage
responsive phosphobinding domain that recognizes proteins phosphorylated by
ATM and ATR after DNA damage. The PTIP tandem BRCT domains are
responsible for phosphorylation-dependent localization of PTIP into 53BP1- and
phospho-H2AX (y-H2AX)-containing nuclear foci, a marker of DNA damage.
Here we report that the BRCT domains of PTIP show strong binding to a
phosphopeptide corresponding to the C-terminus of y-H2AX. In addition, the
BRCT domains of MDC1, MCPH1 and BRCA1 bind to this y-H2AX-like peptide.
We are interested in the role of PTIP in the DNA damage response, however,
after encountering significant hurdles in generating PTIP knockdown cells, we
decided to characterize the budding yeast PTIP homolog, Esc4.
Esc4 is a protein that like PTIP contains six BRCT domains. Esc4 was originally
identified as an enhancer of silencing of chromatin and a regulator of Tyl
transposition. We have found that esc4A arrest in metaphase after DNA damage
after low dose MMS treatment. We also found that deletion of a subset Esc4-
interacting proteins also results in a persistent metaphase arrest. Deletion of
Esc4 results in sensitivity to a variety of damaging agents. We have also shown
that esc4A cells enter S-phase precociously relative to wild-type cells after
synchronization with either alpha-factor or elutriation. In addition, using an
adenine reversion assay, we have shown that esc4A are more mutagenic. We
have demonstrated that endogenously tagged Esc4p interacts with endogenous
PCNA specifically after MMS treatment, but not in undamaged or HU treated
cells. We have demonstrated that esc4A have altered PCNA mobility after UV
irradiation but not after MMS treatment
Concurrently, we have been trying to determine the binding activity of the Esc4p
BRCT domains. We have been unable to demonstrate that Esc4p binds to
phosphopeptides. However, recent work from the Brown lab has shown that
Esc4p fails to be recruited to chromatin after DNA damage in the absence of a
histone acetyl-transferase Rttl09. We have demonstrated, using an in vitro
binding assay, that the BRCT domains of Esc4p bind to peptides containing
acetylated lysines.
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Scope:
In this thesis, I will first discuss the DNA damage response, sources of DNA
damage, how cells signal and repair the damage. I will also discuss the signaling
pathways involved in activating the DNA damage checkpoint. I briefly mention
the role of histone modifications in the DNA damage response.
In the second chapter, I will discuss the discovery of the phosphopeptide binding
functions MDC1 and MCPH1. Additionally, I will discuss some work I performed
on a BRCT domain-containing protein, PTIP.
The third chapter focuses on the function of Esc4, a budding yeast BRCT domain
containing protein that also functions in the DNA damage response and may be
involved in regulating post-translational modifications of PCNA and DNA repair.
Finally, in the fourth chapter I discuss the potential future experiments both
specifically on the PTIP and Esc4p projects and more generally the future
experiments that should aid in our understanding of the DNA damage response
how it cell cycle regulated, and how this response coordinates with DNA repair.
Chapter 1: Sources of Endogenous DNA damage, DNA
Damage Signaling and DNA Repair
The DNA damage response is a fundamental cellular process that is
required for the maintaining genome integrity. This process is essential for many
organismal processes, as mutations in the DNA damage response have been
implicated in cancer risk, premature aging, and neurological defects.
Understanding the DNA damage response has also provided therapeutic
opportunities as DNA damaging agents are utilized to treat cancer patients with
chemotherapy and radiation.
DNA damage occurs spontaneously. DNA is structurally composed of a
phosphophate sugar backbone and nucleotide bases. DNA is inherently
electronegative due to the high content of nitrogen and oxygen atoms and is
therefore highly susceptible to electrophilic compounds. The DNA damage
response has evolved to respond to endogenous sources of damage as well as
damage caused by the external environment.
Endogenous Sources of DNA damage
The DNA damage response has evolved to respond to endogenous sources of
DNA damage. An understanding of endogenous sources of DNA damage is
important for a perspective on the role of the DNA damage response in a non-
laboratory environment. Here we will discuss DNA damage caused by
deamination, oxidative damage, lipid peroxidation, and replication errors.
Deamination
One of the most common spontaneous DNA-damaging events is the deamination
of cytosine to uracil [1]. This event is mutagenic, as uracil pairs with adenosine
whereas cytosine pairs with guanine [2]. Detection and repair of this event is
important to maintain genome integrity. Deamination can become more
problematic in regions of methylated cytosine, as 5-methylcytosine is converted
to thymine. The T-G mismatch is mutagenic and is thought to be an important
cause of human cancer. The prevalence of this transition is useful, as CpG
islands [3], which are regions of GC content greater than 50%, are retained in the
promoters of transcriptionally active regions of the mammalian genome.
Presumably less active regions of the genome have already endured methylation
of cytosines which have undergone deamination into thymine over the course of
evolution[4].
Oxidative damage
Oxidative damage to DNA is also a focus of research in many laboratories [1].
DNA is susceptible to oxidative stress; one such reactive oxygen species is the
highly reactive hydroxyl radical produced from hydrogen peroxide [5]. This
hydroxyl radical is thought to be generated by the Fenton reaction which requires
the presence of a transition metal cation [6]. Transition metals can have
carcinogenic effects; these effects may be in part mediated by the oxidative
damage on DNA [7]. In addition, nitric oxide radicals react with superoxide to
produce peroxynitrite, which is an electrophilic radical capable of reacting with
DNA. These radicals typically react with the double bonds in the nucleotide
base or they abstract a hydrogen from the deoxyribose sugar. Typically these
events lead to single strand breaks.
Other Endogenous Sources of DNA damage
Another endogenous source of DNA damage agent are the products of lipid
peroxidation. These agents are capable of generating DNA crosslinks; the
products of lipid peroxidation are thought to be some of the most reactive
electrophiles in the genome. Finally, another source of mutations can occur by
incorporation of the incorrect base or the incorporation of damaged bases during
DNA synthesis.
Exogenous Sources of DNA damage
External sources of damage that occur in our natural environment include DNA
damage by radiation including ionizing and UV radiation.
Ionizing Radiation
Ionizing radiation (IR) is generated from environmental factors such as Radon
gas and human activities such as medical X-rays [1]. IR is form of high energy
radiation that is can break chemical bonds and is commonly used in the
laboratory setting as a method to generate double strand breaks (DSB). The
gamma-rays emitted from the decay of the cesium-137 source used in the at the
Koch Institute results in 35% of the damage due to ionization of the DNA
molecule itself; conversely 65% of the DNA damage is due to indirect effects,
such as radiation ionizing molecules which in turn react with the DNA. Indirect
effects typically involve the ionization or hydrolysis of water producing a hydroxyl
radical [8]. This causes base damage, most often at the C5-C6 double bond of
pyrimidines. In addition, base dimers are generated as well as protein-DNA
crosslinks. IR produces several damage events in a small vicinity; these damage
events are thought to be initiated from a single particle since the number of
damage events is independent of dose rate, but dependent on total dose applied
[8]. Although IR is typically regarded as a method to generate DSB,
approximately one hundred single-strand breaks is generated for every DSB [8-
16]. In addition, the vast majority of IR induced breaks have aberrant termini,
which prevents them from being repaired by simple re-ligation. In fact the breaks
are often complex, with bases missing.
UV Radiation
Ultraviolet Radiation (UV) is a relevant environmental source of damage that is
encountered by most organisms and has been encountered over the course of
evolution. In the laboratory setting, a typical UV irradiation wavelength is 254nm
[1]. This wavelength of light is readily absorbed by DNA but not by proteins,
making UV a particularly DNA-specific DNA damaging agent. UV irradiation
causes cyclobutane pyrimidine dimers, which are essentially covalent linkages
between adjacent pyrimidines. These are extremely stable lesions that can
survive acid hydrolysis. In addition, UV can damage purines, however these
lesions are more likely to occur when there are greater than two pyrimidines 5' to
the purine. UV can also cause DNA-protein crosslinks; however, DNA-DNA
crosslinks rarely occur after UV irradiation.
Chemical Sources of DNA damage
External chemical agents are capable of damaging DNA. Chemical agents that
damage DNA can be utilized for many functions. For instance, mustard gas, an
alkylating agent, was used as a chemical warfare agent in World War I. In
addition, man-made DNA damaging agents can also be used for less destructive
purposes such as chemotherapy.
Alkylating Agents
An alkylating agent that is specifically used in the lab environment is methyl
methanesulfonate (MMS). MMS exposure specifically generates 7-
methylguanine (7-MeG) and 3-methyladenine (3-MeA) modified bases[1].
Alkylating agents can react with many sites on DNA as the DNA base is highly
unsaturated and presents many chemical opportunities for modifications. The
site of modification depends on the reactivity of the particular damaging agents.
Alkylation weakens the bond between the sugar and the nitrogen-base, and
therefore often results in the formation of abasic sites. Natural sources of
alkylating agents are methyl chloride, which is generated by microorganisms and
S-adenosyl methionine, which generates 7-MeG and 3-MeA.
Crosslinking agents
Crosslinking agents are typically used for chemotherapy[17]. One of the most
common chemotherapeutic agents, dichloro-diamino cisplatin, is a bifunctional
alkylating agents which can cause interstrand and intrastrand crosslinks in
DNA[18]. In addition, DNA-protein crosslinks can also cause DNA damage. This
type of damage normally occurs by the action of aldehydes, which can be
generated by lipid peroxidation as mentioned earlier. This kind of "damage" is
used in the laboratory setting to crosslink DNA to protein for chromatin
immunoprecipitation.
Topoisomerase Inhibitors
Another type of chemical DNA damaging agent commonly used in chemotherapy
are topoisomerase inhibitors[17]. There are two types of topoisomerases,
topoisomerase I and topoisomerase II; topisomerase I relieves helical tension by
generating single-strand break (ssB), conversely, topoisomerase II performs this
function by generating double-strand breaks (DSB). Camptothecin is a
topoisomerase I inhibitor that generates single-stranded breaks, whereas
doxorubicin is a topoisomerase II inhibitor that generates double-stranded breaks
[1].
Mechanisms of DNA repair:
There are five general mechanisms of DNA repair: base excision repair,
nucleotide excision repair, homologous recombination, mismatch repair, and
non-homologous end joining.
Base Excision Repair
Base excision repair (BER) is a process by which a damaged base is removed
by a DNA glycosylase which cleaves the N-glycosidic bond, the bond that
connects the sugar to the nucleotide base [19], to form an abasic site. Abasic
sites are also generated by spontaneous events [20]. A specific subset of
endonucleases recognizes these sites and cleaves the phosphodiester bond
between the abasic site and the 5' nucleotide [1]. Lyases are enzymes that have
both a glycosylase and endonuclease activity; they remove the base and the
associated sugar [1]. The DNA structure after glycosylase and endonuclease
activity differs from the DNA structure after lyase activity, as the sugar associated
with the base is still present after glycosylase/endonuclease activity. A DNA-
deoxyribophosphodiesterase (dRpase) removes the sugar. There are eleven
known human DNA glycosylases and five DNA glycosylases in budding yeast.
Specific base modifications that are removed by these glycosylases include
uracil, 06-methyl guanine, 8-oxo guanine, and various methylpurines. In addition
in some organisms, BER repairs thymidine dimers, by using a a specific
glyosylase that cleaves the N-glycosidic bond 5' to the thymidine dimer; this is
followed by the action of a DNA photolysase or photoreversal to monomerize the
thymidine dimer.
After incision, the gap in the DNA backbone must be repaired. In mammalian
cells, the major polymerase involved in gap-filling is DNA polymerase 3, which
has dRpase activity. After excision of the base, there is either short-patch repair
or long-patch repair. Short-patch repair involves the replacement of one
nucleotide, whereas long-patch repair involves the insertion of 2-8 nucleotides.
Finally DNA ligases are required to complete the process by regenerating the
phosphodiester bond.
PARP in base excision repair: Poly(ADP-ribose) polymerase uses NAD to
ADP-ribosylate proteins. This is an interesting modification that has been of
intense study in the last few years. PARP is activated by strand breaks. PARP
modifies histones, and this modification is thought to open up chromatin because
of the negative charge associated with phosphates in ADP-ribose[21]. PARP
may act as a sensor of sorts for BER, as it binds to single-stranded breaks and it
interacts with many proteins that are necessary for appropriate BER such as
XRCC1, Pol p and Lig 3 [22].
Nucleotide excision repair:
Nucleotide excision repair is a multistep process which involves the cleavage of
the DNA strand surrounding the damaged base, excision of the oligonucleotide
containing the abberant nucleotide, DNA synthesis to repair the gap and, finally,
DNA ligation. NER is the major mechanism to repair UV-induced damage in
mammalian systems[23]. Once a damaged nucleotide is sensed, a 24-32 bp
oligonucleotide is removed[1]. The minimal complex required for NER includes
the proteins XPA, RPA, the XPC-Rad23 complex, ERCC1-XPF complex, XPG
and the TFIIH complex. XPC-Rad23 recognizes the damaged DNA,
presumably by recognizing distortions in the DNA helix and causes further
bending of the helix. In the case of cyclobutane pyrimidine dimers, DNA damage
is recognized by the proteins DDB1 and DDB2. XPA and RPA are also involved
in the damage recognition process. The helicases in the TFIIH complex once
recruited to the site, scan through the region, arresting when a damaged base is
encountered. XPA and XPG, as well as RPA, form an open complex at the
location of the damaged DNA. Then a 3' incision is generated by XPG and a 5'
incision is generated by ERCC1-XPF complex. The oligonucleotide containing
the damaged base is removed. The DNA repair polymerases, Pol E and Pol 8
are both likely involved in gap filling after NER, but Pol 8 may be the more
relevant polymerase[24, 25].
The NER systems that is involved in repairing actively transcribed DNA is
called transcription-coupled repair (TC-NER); in contrast, NER based repair of
the rest of the genome is called global genome repair (GGR) [1]. The difference
between these two processes appears to be determined by the mechanism of
detection. NER also repairs transcriptionally active DNA more efficiently than
non-transcribed DNA. In fact, the strand that is actively being transcribed is more
efficiently repaired than the complementary strand. TC-NER does not require
XPC or the DDB proteins [26], but instead uses RNA polymerase stalling as a
mechanism of detection [27].
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Mismatch repair:
Mismatch repair (MMR) is the process by which mismatched bases are identified
and repaired [1]. Mismatches can occur during DNA replication. A critical step in
MMR is recognizing which strand corresponds to the parental strand, and which
strand is the newly synthesized strand that contains the incorrect nucleotide. In
E.coli, this is elegantly accomplished as the parental strand is methylated at the
adenine of GATC nucleotide sequences. How the correct strand is identified in
eukaryotes is unclear, although recent evidence indicates that the processivity
clamp, PCNA, may provide a way of orienting the DNA repair machinery in terms
of which strand is newly replicated. In addition, the MMR may detect nicks in the
strand, and the lagging strand which contains Okasaki fragments contains
nicks[28]. Therefore distinguishing the nicked strand from the unicked strand
may be a successful method to distinguished between the newly replicated and
the parental strand.
Recognition of the mismatch occurs by the MSH heterodimeric complex
termed MutSa [1]; the DNA is nicked by the MutLa complex either 3' or 5' to the
mismatch, the DNA is hydrolyzed by a single strand exonuclease, EXO1, and
the DNA is resynthesized by either Pol E or Pol 8. Abnormalities in mismatch
repair appears to be involved in certain types of chemotherapy resistance, as
some DNA damaging agents, such as MNNG and cisplatin, require an active
MMR system in order to cause cell death.
Homologous Recombination
Homologous Recombination is a process by which homologous DNA is used as
a template for repair of a double-strand break. This process typically uses a
sister chromatid and occurs preferentially in the S and G2 phases of the cell
cycle. There are two proposed mechanisms of HR [1], including double-strand
break repair (DSBR) and synthesis dependent strand annealing (SDSA). Both
processes require resection of the DSB to a single-stranded region. However,
the extent to which the homologous chromosome is used as a template for repair
differs between the two processes. DSBR basically results in a full crossover
event, whereas SDSA, uses only a part of the sister chromatid as a template.
This process is more heavily used in mitosis. Single strand annealing is a
process that occurs in regions of repeats within the same chromosome. Break-
induced replication is another process that occurs during S-phase after a
collapsed replication fork, where one strand of ssDNA invades a region of
homology.
The detailed mechanism of homologous recombination has been best
elucidated in budding yeast. In mammalian cells, the first step of HR is the
generation of ssDNA and the coating of the DNA with the RecA-like Rad51
protein [1]. This complex forms the recombinogenic nucleoprotein filament or the
presynaptic filament. This process is opposed by the Sgsl and Srs2 helicases.
Rad52, the Rad55-57 complex and Brca2 in mammalian cells help to stabilize
the presynaptic complex by preventing or displacing the binding of RPA to the
ssDNA. Rad52 helps to recruit Rad51 to ssDNA, displacing RPA from the
22
filament [2]. Rad55-57 also bind to Rad51 and aid in the displacement of RPA
from ssDNA [29].
Once the Holliday junction is formed by invasion of the presynaptic
filament into the homolgous DNA, Holliday junction resolution must occur. The
specific enzyme involved in this process has not been identified in eukaryotes.
However a DSB is required to resolve the junction, as well as religation of the
recombined DNA.
Non-homologous end joining
Non-homologous end joining is a mechanism of DSB DNA repair that dominates
the G1 phase of the cell cycle. DSBs are first recognized by the DNA binding
proteins Ku70-Ku80, which are present at very high concentration in the nucleus.
The binding of Ku70-Ku80 to the free DNA ends recruits the catalytic subunit of
DNA-activated protein kinase DNA-PKcs, thereby activating the kinase. The
DNA ends are processed, if necessary, by Artemis (a nuclease), DNA Polk or
DNA Pol [ to generate regions of microhomology. Ligation of the DSB occurs by
the DNA ligase complex Lig4/XRCC4. It is unclear from the literature if the MRN
complex is also involved in processing DNA ends to generate the correct DNA
structure for DNA repair. It is possible that the confusion is one of kinetics[1],
the MRN complex may arrive first to the site of damage, resect the break in order
set up the checkpoint, while the repair proteins may take more time to be
recruited and they may process the DNA further to the correct structure for repair
[30, 31].
DNA damage signaling
How DNA damage is repaired is unique to each lesion. However, it is thought
that DNA damage signaling pathway often recognizes damage by the gross
changes that DNA damage induces in chromatin structure. DNA damage
generally activates a signaling cascade that functions to halt the cell cycle and
organize repair, and in the mammalian setting, signal for apoptosis if damage is
extensive.
ATM and ATR, phosphatidylinositol 3-kinase-like family members, are the
central transducer kinases of the DNA damage response[32]. ATM and ATR
differ in the types of lesions they respond; ATM preferentially responds to double
strand breaks (DSBs)[33, 34]; whereas, ATR responds to bulky lesions, single
strand breaks (SSBs), DSBs and stalled replication forks[35-37](refer to Figurel).
ATM/ATR activate a secondary set of transducer kinases: Chkl and Chk2. Chkl
is downstream of ATR; ATR phosphorylates Chkl on residues S317 and
S345[38]. Chk2 is downstream of ATM and is phosphorylated on T68 by
ATM[39]'[40]. Chkl and Chk2 regulate the cell cycle checkpoint by
phosphorylating the effectors.
ATM and Chk2 are not essential kinases, whereas ATR, and Chkl are
essential. This suggests a fundamental difference in the overall roles in these
kinases. ATR and Chkl are thought to be particularly important for signaling and
responding to S-phase replication stress. This kind of damage is encountered in
every S-phase of a mammalian cell it is important to have an intact DNA damage
response to allow for replication through numerous lesions. Loss of ATR and
Chkl is thought to result in a loss of replication fork stability, and inability to
replicate DNA. DNA replication is an essential process; therefore loss of Chkl or
ATR fundamentally destabilizes an essential process and results in defects in cell
viability.
ATM
How DNA damage is detected differs between ATM and ATR. ATM is thought to
exist in inactive multimers in an undamaged cell, as the FAT domain of ATM is
binding to and inhibiting the kinase domain of ATM in trans. However, after DNA
damage, ATM rapidly autophosphorylates on Ser1981, thereby relieving this auto
inhibition as the FAT domain cannot bind the kinase domain in its phosphorylated
form (Figure 1-1 B). The mechanism of activation of ATM is not currently
completely clear. It is thought to depend on the action of the Mrel 1, Rad50,
Nbsl complex (MRN) (Figure 1-1A). Mrel contains an exonuclease activity;
this protein might modify lesions in such a way that ATM can recognize the
damage event. In addition, it has been shown that knockdown of Mrell reduces
the amount of phosphorylation of some ATM substrates, at low but not high
levels of damage. It is likely that the action of Mrel 1 maybe to amplify the
damage signal in some way. Nbsl is also a substrate of ATM, and is thought to
exist in a positive feedback loop with ATM as Nbsl phosphorylation may act to
further activate ATM[41]. There is also evidence that artificial tethering of the
MRN complex can localize and cause the activation of ATM. Regardless, upon
double-strand break formation, ATM and the MRN complex rapidly relocalize to
the site of the break. ATM phosphorylates the histone variant H2AX, which
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appears to be pre-existent at chromatin, at Ser139 and Thrl 36. This
phosphorylation event can be visualized using immunofluoresence and it occurs
rapidly after IR treatment. Phopho-H2AX (also called y-H2AX) localizes to
distinct foci that are thought to be sites of DSB. Much of the evidence that foci
formation occurs at the actual sites of damage comes from studies in which very
small beams of high energy UV light are used to irradiate cell cells that have
been grown in the presence of BrdU. UV treatment, results in the decomposition
of BrdU and the formation of DSBs. Utilizing these beams, a single line through
the nucleus is irradiated. As y-H2AX staining only occurs in the path of the
beam, the conclusion is that H2AX is phosphorylated at or near sites of DSBs.
H2AX phosphorylation is one of the first chromatin modifications that occur in
order to generate macromolecular complexes around the site of DSB. H2AX
recruits the BRCT-domain containing protein MDC1. MDC1 binds to the C-
terminus of phosphorylated H2AX. MDC1 binding is required for checkpoint
maintenance; in the absence of MDC1, H2AX is not stably phosphorylated [42].
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Figure 1-1: The importance of Protein Phosphorylation in the DNA damage
response:
A. ATM and the MRN complex are recruited to sites of DSBs, where ATM is
activated and phosphorylates several targets, including the MRN complex
and H2AX. Phosphorylation of the MRN complex is thought to contribute to
ATM activation
B. ATM phosphorylation leads to release of active ATM monomers, Chk2
activation and Cdc25 seqesteration by the generation of a local
phosphopeptide binding motif created by Chk2 phosphorylation. This local
phosphopeptide binding motif is recognized by 14-3-3.
ATR
ATR is a large kinase with significant sequence homology to ATM. Many
different lesions activate ATR, but the common denominator is thought to be
RPA-coated ssDNA [43]. ATR exists in a heterodimer with ATRIP, these two
proteins are thought to always be in a complex. ATRIP specifically interacts with
RPA coated ssDNA. Beyond the requirement for ssDNA, there needs to be a
5'junction for proper ATR activation [44]. More recently it was found that
biochemically, ATR kinase activity is enhanced in the presence of the BRCT
domain containing protein TOPBP-1[45]. It has been shown that there is an ATR
activation domain in TOPBP-1 located between BRCT domains six and seven
that is necessary and sufficient for ATR activation. TopBP-1 is thought to
localize to site of DNA damage through a phosphospecific interaction between
Rad9 of the 9-1-1, PCNA-like complex and BRCT domains one and two of
TopBP-1[43]. More mechanistically, it is the recruitment of TopBP-1 to the 9-1-1
complex and the colocalization of TopBP-1 with ATR that activates ATR kinase
activity. Keeping the other lesions that ATR responds to in mind, it is interesting
to note that these observations constitute some evidence that there may be RPA-
independent mechanisms for ATR activation, as is likely the case with mismatch
repair proteins.
One of the most important downstream targets of ATR is the kinase Chkl. Chk1
is thought to be recruited to replication forks via its interaction with an adaptor
and activator protein, claspin. Concommitant with activation, Chkl is
phosphorylated at Ser317 and Ser345. Interestingly these sites are not SQ sites,
therefore although they depend on ATR activity, they may not be directly
phosphorylated by ATR itself [21].
In addition to activating Chkl, ATR kinase activity is thought to inhibit
origin firing and may inhibit replication elongation. However, ATR also promotes
the firing of dormant origins after stress [20]. It is unclear how this occurs
mechanistically, however, there is evidence in the literature that Plkl is involved
in activating these origins by binding to MCM2 on a phospho-site generated by
ATR. These contradictory functions of ATR could also be regulated by timing: at
early times after damage, ATR might directly inhibit origin firing while
simultaneously generating a binding site for Plkl, so that upon checkpoint exit,
activation of Plkl, a cell-division promoting kinase, now mediates the switch
between repressed DNA synthesis to activated DNA synthesis [22].
In addition to the role of ATR in cell cycle arrest, ATR also has a function
in DNA repair. ATR phosphorylates proteins involved in HR such as BRCA1, the
Werner's syndrome helicase and the Bloom syndrome proteins, as well as the
Fanconi-anemia proteins involved in inter-strand crosslink repair and the NER
protein XPA.
Although ATM is thought to be primarily involved in mediating the cellular
events that follow double strand DNA breaks, ATR is also, in fact, important for
DSB signaling and repair. ATR is activated in the DSB response, and checkpoint
maintenance after DSB is impaired in the absence of ATR.
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ATR, unlike ATM, is an essential kinase, likely due to its role in normal S-
phase progression. In yeast, deletion of the ATR homolog, Mecl is lethal,
however, upregulating dNTP production bypasses this lethality associated with a
mecIA. Similarly, in mammalian cells upregulating dNTP production suppresses
the lethality associated with loss of ATR. In addition, ATR is thought to stabilize
replication forks as they encounter a lesion or particularly hard to replicate
regions of the genome. In agreement with this, there is an increase of fragile site
breakage in ATR-deficient cells, as well as an increase in double strand breaks.
Chk1, Chk2, MK2
Chk1, Chk2, and MK2 are all downstream effector kinases of the DNA damage
response that do not remain localized to the site of the break, but communicate
to the rest of cell that there is a DNA damage checkpoint [21]. These kinases are
basophilic kinases; they generally require that their substrates contain an
arginine residue in the -3 position (i.e. 3 positions N-terminal) relative to the
serine or thereonine which will be phosphorylated [41]. These proteins share
several key targets: p53, and Cdc25 family of phosphatases. For the purposes
of this thesis, I will discuss Chkl [23].
Chk1 activates the G1/S- and G2/M checkpoints by phosphorylating and
stabilizing p53 on Ser20, and the CDC25 family of phosphatases. Chkl
phosphorylation of CDC25B and C family members generates a phosphopeptide
binding motif that is recognized by 14-3-3 and results in the relocalization of
CDC25B/C to the cytoplasm, away from their Cdk1 substrates to establish the
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G2/M checkpoint [23], while Chkl phosphorylation of Cdc25A results in its
ubiquitin-mediated proteolysis, establishing the G1/S checkpoints.
Cell cycle dependence of DNA repair and DNA signaling.
The mechanism used to repair a DSB is dependent on the particular phase of the
cell cycle [24]. During S-phase/G2, the preferred mechanism of repair is
homologous recombination due to the presence of sister chromatids held
together by cohesin complexes. During G1, the preferred mechanism of DNA
repair is NHEJ, as the source of homology would be the homologous
chromosome which is not necessarily nearby the damaged chromosome. The
switch between HR and NHEJ is interesting and complex and is just now
beginning to be understood.
One of the key parts of the regulation of this pathway is the activity of
ATR. Jayzeeri et al. showed that ATR is activated in response to DSB in S and
G2 but not in G1. Both S and G2 phases correspond to the points in the cell
cycle when CDK activity is high. Under these conditions, CtlP binds to the MRN
complex, and promote DSB resection, and recruitment of ATR/ATRIP.
Ku70/Ku80, which are required for NHEJ are in theory able to bind to free DNA
ends with high efficiency, as there is a very high concentration of Ku70 and Ku80
in the nucleus. However, there is evidence that PARP may function to reduce
the affinity of Ku proteins to DSBs during times of high CDK activity, so that HR is
favored in S/G2.
DNA damage in budding yeast:
Many insights into the DNA damage response emerged from studies of budding
yeast. There are many similarities in DNA damage signaling between single
celled eukaryotes and more complex organisms. For instance, the budding yeast
homolog of ATR, Mecl, requires the binding function of Ddc2 the homolog of
ATRIP in order to bind to RPA coated ssDNA. Mecl then phosphorylates the
tandem BRCT domain containing protein Rad9, generating a phosphodocking
site for the FHA domain of the Chk2 homolog Rad53. Unlike mammalian
systems, where the essential checkpoint kinase is Chkl, Rad53 is the essential
checkpoint kinase in budding yeast; whereas Chkl has a more secondary role in
the budding yeast DNA damage response. The binding of Rad9 to Rad53
causes the autophosphorylation and subsequent activation of Rad53. Chkl is
also activated by Mecl in a Rad9 dependent manner. Since budding yeast lacks
a canonical G2 checkpoint, the post-S phase cell cycle arrests at metaphase,
blocking mitotic exit. The main target of the yeast cell cycle checkpoint is Pdsl
securin (Figure 1-2). Phosphorylation of Pdsl stabilizes it, thereby preventing
securing cleavage by separase, and blocking the metaphase to anaphase
transition.
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Figure 1-2: Pdsl is the target of the DNA damage response in budding
yeast : Unlike in mammalian cells, the budding yeast DNA damage response
targets Pdsl (securin). Both the activities of Chkl and Rad53 stabilize Pdsl. In
addition, the spindle checkpoint also stabilizes Pdsl, as it does in mammalian
cells.
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The role of PCNA in the DNA damage response.
PCNA is the processivity clamp that is essential for normal replication of DNA.
By completely surrounding the DNA as a homotrimeric ring, PCNA increases the
processivity of DNA polymerases by tethering them to DNA and is an essential
manager of DNA synthesis. Since DNA lesions are likely to be encountered
during every round of mammalian DNA replication, PCNA is a teleogically ideal
protein to be involved in the sensing and resolution of these lesions.
Many proteins interact with PCNA by binding to a short sequence region
called the PIP box, which contains the minimal motif Qxxp, where "x" denotes
any amino acid and V denotes the aromatic amino acids FlY. Proteins such as
RFC, the clamp loader, Cdtl which is important for replication licensing and
members of the DNA mismatch repair machinery interact with PCNA through the
PIP box. In addition, PCNA is modified on two key residues(see Figure 1-3).
The first of these is K164 [25]; this residue can be mono-ubiqutinylated, poly-
ubiquitinylated or SUMO-modified [26]. Monoubiqutination depends on Rad6
and Rad 18, and is associated with translesion polymerase activity, as subset of
which have ubiquitin binding domains, while polyubiquitination promotes template
switching and requires Rad5. Finally, SUMO-modified PCNA recruits the
helicase Srs2, which disrupts Rad51 nucleofilament formation, and therefore
suppresses homologous recombination [46].
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Fiqure 1-3: PCNA Post-translational Modifications: PCNA can undergo
several modifications which regulate PCNA activity. SUMO-modification results
in a repression of Homologous Recombination, monoubiquitination results in the
recruitment of TLS polymerases, polyubiquitination results in error-free repair
presumably through template-switching.
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Histone code and the DNA damage response
Histones undergo a wide variety of modifications including ADP-ribosylation,
phosphorylation, acetylation, ubiquitylation, and sumolyation. Histone
modifications are likely to be a key part of the DNA damage response [27]. This
seems completely logical as histone proteins are closely associated with DNA,
and are already known to affect the compaction state of chromatin. Intuitively, an
open DNA structure would be important in order to provide access to DNA repair
proteins [28] [29], although with the exception of yH2AX, the role of histone
modifications in the DNA damage response is only now beginning to be explored.
ADP-ribosylation
ADP-ribosylation of histones is thought to open up the chromatin structure, aiding
in the accessibility of DNA to the NER machinery [30]. PARP-1 is a key enzyme
in this process. The negative charge of the ADP-ribose polymers is thought to
electrostatically repel the DNA backbone. In addition, there is some evidence
that part of the function of PARP-1 may be to affect the ATP/ADP ratio in the cell
which may alter the checkpoint versus apoptosis decision [31].
Phosphorylation
Histone phosphorylation is a key event after DNA damage, and has been the
post-translational histone modification that has been most thoroughly studied in
this context. H2AX appears to be phosphorylated for a region extending -50kBp
around the DSB in budding yeast, and for MBp regions around the break in
mammalian cells. H2AX promotes the maintenance of proteins at the site of the
break, although in the absence of H2AX, the initial recruitment of these proteins
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after DNA damage is intact. Phospho-H2AX recruits the BRCT domain-
containing protein MDC1, and this results in a cascade of interactions that
ultimately culminate in recruitment of BRCAI.
Acetylation:
Acetylation is a general chromatin modification that is thought to result in open
chromatin. Sin3p/Rpd3p in yeast are HDACs that are involved in deacetylating
H4K16. This modification is lost specifically around the sites of DSBs. (An acetyl
mimicking mutation of H4K16Q, can cause impaired NHEJ response [52, 53].
The reasons for this are unclear, but it is possible that a more open chromatin
state favors HR or that the local concentration of DNA damage proteins must be
higher in order to facilitate NHEJ [32] [54]. Around sites of HO-induced breaks,
there has been evidence of acetylation of Lys8 at Histone H4 [55]. This
acetylation event is absent in strains that are unable to perform homologous
recombination at the mating-type locus.
In addition the Tip60 histone acetylase and ATPase may be involved in
acetylating and removing of H2AX from chromatin [56]. There is also evidence
from embryonic stem cells lacking Tip60, that H4 hyperacetylation is lost around
the sites of DSBs, which seems to impede repair.
Finally, 53BP1 is a DNA damage mediator protein that is thought to bind
to methyl-H3K79 [57], although this is contraversial. The role of this modification
in the recruitment of 53BP1 has long been enigmatic. However, more recently it
has been argued that histone acetylation around the sites of the break may
exposed local regions of methyl-H3K79, thereby recruiting 53BP1.
Ubiquitination
Several years ago, it was reported by the Bartek lab that GFP-ubiquitin
formed foci after DNA damage. More recently, it has been shown that Histone-
H2A and H2AX are ubiquitinated after DNA damage. The exact role that this
modification has on chromatin structure is unclear, however, this modification
does act as a platform for the recruitment of the BRCA-1 interacting protein
Rap80, which contains a ubiquitin interaction motif[58-62]. RNF8, an FHA
domain-containing phosphopeptide binding protein, that interacts with MDC1, is
thought to be the enzyme that modifies H2A and H2AX to facilitate BRCA1
recruitment [63] [64] [65].
Applications of the our understanding of the DNA damage response:
It is important to note that the DNA damage response is an important target of
many chemotherapeutic agents [9]. It is thought that the reason cancer cells are
more susceptible to DNA damaging agents are two-fold. The first reason is that
some of these DNA damaging agents specifically target dividing cells. For
instance, many lesions interfere with DNA replication. Cancer cells as well as
other dividing cells in the body such as hematopoietic cells are susceptible to
these agents. The second reason is that genomic instability is a hallmark of
advanced cancer cells. These cells, in order to be genomically unstable, have
crippled aspects of their DNA damage response. Because of this, they are more
sensitive to, and/or less able to repair these lesions. Impaired repair, however, is
not generally seen across all tumor cells because there is evidence that
treatment with chemotherapy can often lead to the selection of resistant cells that
have upregulated their DNA repair capacity [66-68].
DNA damage and aging?
Is DNA damage the cell clock, the unit of cellular aging? Whereas telomeres are
broadly recognized as a way to regulate the number of cell divisions undergo,
telomeres in mice are significantly longer than in human cells, and mice live an
average of two years, whereas humans live on the order of decades. In addition,
recent studies have shown that shortened telomeres expose a single stranded
tract of DNA that activates the DNA damage response as part of the mechanism
of cell senescence. However, there is evidence that NER in mice is less efficient
than in humans, and this may correlate with the shorter life-span of rodents. In
addition, numerous studies have demonstrated the reduced repair in capacity of
aged cells and tissues. Interestingly, caloric restriction, which is thought to
prevent oxidative stress also correlates with a reduction in DNA damage.
Whether this reduction in genotoxic stress constitutes causation or correlation
with respect to ageing is unclear.
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Chapter 2: Identification of New Phosphopeptide binding
BRCT domains
BRCT domains are contained in many DNA damage proteins. Previously, our
lab and others have shown that the BRCT domains of BRCA1 and PTIP bind to
phosphopeptides generated by the DNA damage kinases ATM and ATR.
The objective of this work was to identify and characterize phosphopeptide
binding BRCT domains.
The first part of this chapter deals with identifying pH2AX-binding proteins; the
second part of this chapter summarizes our work on PTIP.
Some of the material in this chapter has been published in:
Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP.
MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses
to DNA double-strand breaks.
Cell. 2005, 123:1213-26.
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Introduction:
The DNA damage response: The DNA damage response is required to
maintain genome stability and organismal survival. The DNA damage response
coordinately signals to repair DNA damage and halt the cell cycle until repair is
complete; if the cell cannot repair the damage, the DNA damage pathway also
mediates the apoptotic signal. Members of the DNA damage response are
classified as sensors, mediators, transducers and effectors. Sensors recognize
the damage and signal the presence of damage to the transducers. Transducers
relay the signal to the effectors, which are the ultimate downstream targets, as
they arrest cell cycle and begin DNA repair. Mediators function to enhance
signal transmission by stabilizing substrate kinase interactions[37].
ATM and ATR, phosphatidylinositol 3-kinase-like family members, are the
central transducer kinases of the DNA damage response[32]. ATM and ATR
differ in the types of lesions to which they respond; ATM preferentially responds
to double strand breaks (DSBs)[33, 34]; whereas, ATR responds to bulky lesions,
single strand breaks (SSBs), DSBs and stalled replication forks[35-37] (refer to
Figurel). ATM/ATR activate a secondary set of transducer kinases: Chkl and
Chk2. Chk1 is downstream of ATR; ATR phosphorylates Chkl on residues
Ser317 and Ser345[38]. Chk2 is downstream of ATM and is phosphorylated on
Thr68 by ATM[39]'[40]. Chkl and Chk2 regulate the cell cycle checkpoint by
phosphorylating the effectors.
Effectors differ in the type of arrest they induce. For a G1/S arrest, the
effector p53 is stabilized by phosphorylation on Serl 5 by ATM/ATR[76-79] and
Ser20 by Chk1/2[80], resulting in the transcription of the CKI (cyclin dependent
kinase inhibitor) p21. Other effectors include the Cdc25 family of mitotic
phosphatases
Mediator proteins, which function to stabilize kinase substrate interactions,
are a newly added group of proteins involved in the DNA damage response. The
majority of these proteins are BRCT-domain-containing proteins such as 53BP1,
MDC-1, TopBP-1, and BRCA1[81-84]. These proteins are thought to act as
molecular scaffolds that can bind both ATR/ATM and the ATM/ATR substrate
and enhance phosphorylation.
BRCT domains are found in many proteins critically important in the DNA
damage response.
The critical role of BRCT domain containing proteins in the DNA damage
response is conserved from budding yeast to metazoans. In fact, there is
evidence that certain prokaryotic proteins contain BRCT domains. Budding yeast
have ten BRCT-domain-containing proteins, whereas mammalian cells have at
least twenty-five (see Table 1, 2). What is obvious from scanning the functions of
the human BRCT domains is that all BRCT-domain containing proteins function
in the DNA damage response. BRCT-domain-containing proteins have important
biological functions; therefore, studying BRCT domains may provide insight into
critical cellular processes such as cell cycle regulation and the DNA damage
response.
BRCT domains are thought to be primarily protein-protein interaction
domains. However, a subset of BRCT domains may interact with DNA. The
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term "tandem-BRCT domains" was coined to describe a pair of BRCT domains in
proximity to each other [85, 86], as BRCT domains often appear in multiples of
two within the same protein. A BRCT domain is structurally composed of two or
three alpha helices surrounding a beta-sheet [42, 86]. The structure of fifteen
mammalian BRCT-domains or tandem-BRCT domains has been solved. This
domain structure of the BRCT domain is fairly conserved, however the amino
acid conservation is low, particularly around regions of low secondary structure.
The founding member of the BRCT domain family is the Breast Cancer
Associated Gene 1 (BRCA1). The term BRCT domain is derived from BRCA1 C-
Terminal Domain. BRCA1 contains two BRCT domains in its C-terminus, as well
as a RING domain at the N-terminus. BRCA1 is an essential gene as knockout
of this gene in mice results in early embryonic lethality. BRCA1 has functions in
the cell cycle during S-phase and during cytokinesis. It has many important roles
in the DNA damage response, both as a signaling molecule and in mediating
repair. BRCA1 deficient cells are sensitive to DSBs, and BRCA1 null cells are
defective in homologous recombination[87], resulting in increased error-prone
DNA repair such as NHEJ, which can result in translocations, a hallmark of
cancer. BRCA1 was identified because mutations in BRCA1 are associated with
an increased risk of breast and ovarian cancer [86]. Mutations in BRCA1 are
found in approximately half of women with hereditary breast cancer [87, 88].
Importantly, most cancer-associated mutations of BRCA1 affect the BRCT
domains: the majority of point mutations are in the BRCT domains, and most
frameshift mutations and deletions also disrupt the BRCT domains (See Figure
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2-1B). The BRCT domains are critical for the tumor suppressor function of
BRCA1.
Ionizing-radiation-induced foci formation of BRCA1 protein requires the
BRCT domains of BRCA1. Localization to foci after DNA damage is essential for
the repair function of BRCA1. Deletion of the BRCA1 BRCT impedes foci
formation [88]. However, until recently, the molecular function of the BRCA1
BRCT domains was unclear. The structure of a subset of cancer-associated
point mutations in the BRCA1 BRCT domains has been solved; interestingly, the
structure of the M1775R mutant BRCT domains of BRCA1 is structurally similar
to WT BRCA1. From the crystal structure alone, it is unclear why the tumor
suppressor function of BRCA1 was lost with the M1775R mutation.
Using a peptide library screen, our lab discovered that a subset of BRCT
domains function as a phosphopeptide-binding domain that bind to ATM/ATR
substrates. The phosphopeptide binding activity of BRCA1 was functionally
important because it is lost in the common cancer associated mutation of
BRCA1, M1775R (see figure 2-1) [85]. Work performed by our lab and others
has demonstrated that there are five known mammalian phosphopeptide-binding
BRCT domains, PTIP, BRCA1, MDC1, MCPH1 and TopBP1[85, 86] [42].
Phosphopeptide-binding BRCT domains differ in their binding preferences.
All phosphopeptide-binding BRCT domains have the greatest discrimination in
the position three amino acids C-terminal to the phosphoserine (the +3 position)
[85]. BRCA1 BRCTs prefer aromatic residues in the +3 position [85] [86]. In
contrast, the BRCT domains of PTIP will bind to aliphatic or aromatic residues in
the +3 position [42].
Part1: Identification of Novel Phosphopeptide binding BRCT
domains:
The objective of the work in this section was to identify new phosphopeptide
binding BRCT domains.
One of the earliest events in the DSB DNA damage response is the
phosphorylation of the C-terminal tail of H2A.X, an H2A histone variant. The tail
of H2AX contains two potential ATM/ATR phosphorylation sites: Thrl 36, and
Serl39[42, 89]. The amino acid sequence of the C-terminal tail of H2AX is:
SGGKKAT 136QAS139QEY-COOH. Of note, the amino acid in the +3 position of
this peptide is tyrosine, which, as we discussed in the introduction, is preferred
by the BRCT domains of BRCA1.
Phosphorylation of H2AX is a critical event for the DNA damage response,
as knocking out H2AX results in genome instability, checkpoints defects and
impaired foci formation of downstream effectors. These defects cannot be
rescued by a S139A mutation of H2AX. Proteins such as 53BP-1 are transiently
localized to foci in the absence of H2AX, but their localization and the DNA
damage checkpoint are not maintained [89].
We hypothesized that there may be proteins that bind to the C-terminus of
H2AX that may not bind to internal phosphosites as the C-terminus of a protein
presents a unique electrostatic and steric considerations. One can imagine a
domain that binds to a phosphoepitope at the C-terminus but not an internal
phosphosite, as the C-terminus would have additional negative charge due to C-
terminal acid which would provide opportunites for electrostatic interactions
between the binding domain and the ligand. In addition, the binding cleft of this
hypothetical domain could be physically smaller so as to only accept a C-terminal
phosphoepitope. Conversely, one could imagine that such an adapted domain,
would not accept a peptide that was internal, as the ligand would sterically clash
with protein, or fail to have the proper hydrogen-bonding contacts in the absence
of the C-terminal acid.
Because the tyrosine in the +3 position of H2AX, we hypothesized this
domain would be a BRCT domain. The peptide library used in previous studies in
our lab had the sequence pSF=MAXXXXpSXXFXXAKKK-NH2. We generated
peptide libraries that mimicked the C-terminus of H2AX, with the sequence pSer-
CT =MAKKKY XXXXpSXXX-COOH. The new peptide library had two major
features, first the phosphoserine is three amino acids away from the C-terminus,
second, the peptide terminates in an acid rather than an amine. As stated
earlier, we hypothesized that the unique characteristics of a C-terminus provides
a specificity that would prevent a protein from binding the first-generation libraries
that had both extra lysines at the C-terminus and did not have the added
negative charge of the free acid.
We screened eight tandem BRCT domains for H2AX-like peptide binding:
Ect2, BRCA1, Rad9, PTIP, MDC1, NBS1, Bank1, and MCPH1. In addition, we
screened full-length PTIP, which contains six BRCT domains (Figure 2-2). We
observed phosphospecific binding in the BRCT domains of PTIP, BRCA1,
MDC1, and MCPH1. BRCA1 and PTIP were previously known to bind
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phosphopeptides, therefore, the phosphospecific binding of these proteins to a
modified peptide library was not unexpected. However, the binding of MDC1 and
MCPH1 to the H2AX-like library constituted the identification of two new
phosphopeptide binding proteins (Figure 2-2). Having established that MDC1
and MCPH1 bind the H2AX-like library in a phosphospecific manner, we wanted
to determine if their binding required the free C-terminus, or if MDC1 and MCPH
could bind the traditional peptide libraries.
In Figure 2-3 and 2-4, we demonstrate that MDC1 and MCPH1 bind the
H2AX-like library (the lane labeled pSer-CT), but not the traditional libraries.
Therefore, the binding requirements of MDC1 and MCPH1 are distinct from the
BRCT domains of BRCA1 and PTIP because BRCA1 and PTIP can bind to both
libraries. In addition, we performed a sequence alignment of MCPH1 with
BRCA1 and identified potential residues that might mediate phosphopeptide
binding. Despite the differences between the binding requirements of BRCA1
and MCPH1, mutation in MCPH1 based on the structure of BRCA1 abrogated
phosphospecific binding, indicating that some of the structural elements involved
in phosphospecific binding are conserved between MCPH1 and BRCAI.
Next, we quantitatively determined the amino acid preferences in each
position using oriented peptide library screening (OPLS). We found that MDC1
has an almost four-fold preference for tyrosine in the +3 position; significantly,
tyrosine is the residue in the +3 position relative to Ser-139 of H2AX. MCPH1
also has a preference for tyrosine but only 1.8 fold more than an unselected
amino acid. Using this information, we performed a bioinformatics screen for
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ligands for MDC1 and MCPH1. The predicted ligand with the highest sequence
similarity was H2AX for both proteins [42]. The role of MDC1 in DNA damage
checkpoint maintenance and the phosphopeptide binding function of the MDC1
BRCT domains has been published this publication is in Appendix 1.
Although bioinformatics screening indicated that MCPH1 could interact
with phospho-H2AX, our collaborators in the Jackson lab could never obtain
convincing biological data supporting this interaction. However, there are recent
publications reporting an interaction between MCPH1 and phospho-H2AX [90].
We think that it is likely that MCPH1 may have other ligands given that tyrosine is
not highly selected for in the +3 position.
In conclusion, in this section, we identified two new phosphopeptide-
binding BRCT domains: MDC1 which is a phospho-H2AX-binding protein, and
MCPH1, which may bind to phospho-H2AX as well.
Fiqure 2-2: MDC1, MCPH1, PTIP and BRCA1 bind to the H2AX-like
phosphopetide library.
The tandem BRCT domains of ECT2, BRCA1, RAD9, PTIP, MDC1, NBS1,
BANK1, and MCPH1 cDNAs were in vitro translated in the presence of 35S-
methionine and incubated with phospho- and non-phosphopeptide libraries. The
phosphopeptide libraries used were S=XXXXSXXXXAKKK and
pS=XXXXpSXXX. Phosphospecific binding was defined as a preference for the
pS library. The tandem BRCT domains of BRCA1, PTIP, MDC1 and MCPH1
interacted more strongly with the pS library.
ECT2 BRCA1
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Rad9 PTIP
10% S pSIO% S pS
MDC1 NBS1 BANK1 MCPH1
10% S pS 10% S pS 10%S pS 10%S pS
FL PTIP
10% S pS
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Figure 2-3: The BRCT domains of MDC1 bind to phosphopeptides with a
free acid at the C-terminus
A. The MDC1 tandem BRCT domain binds to C-terminal phosphopeptide motifs.
The peptide libraries used were pSer = XXXXpSXXXXXAKKK, pSer-CT =
XXXXpSXXX, Ser = XXXXSXXXXXAKKK, pSF = XXXXpSXXFXXAKKK, SF =
XXXXSXXFXXAKKK, pThr = XXXXpTXXXXXAKKK, Thr = XXXXTXXXXXAKKK,
pSQ = XXXB(pS/pT)QJXXXAKKK, and SQ = XXXB(S/T)QJXXXAKKK. B/C The
optimal motif of the tandem BRCTs of MDC1. Bar graphs show the relative
abundance of each amino acid at a given cycle of sequencing compared to its
abundance in the starting peptide library mixture
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Figure 2-4: The BRCT domains of MCPH1 bind to phosphopeptides with a
free acid at the C-terminus
A. The MCP1 tandem BRCT domain binds to C-terminal phosphopeptide motifs,
and a mutant predicted to fail to bind phosphopeptides does not interact with the
C-terminal phosphopeptides. The peptide libraries used were pSer =
XXXXpSXXXXXAKKK, pSer-CT = XXXXpSXXX, Ser = XXXXSXXXXXAKKK,
pSF = XXXXpSXXFXXAKKK, SF = XXXXSXXFXXAKKK, pThr =
XXXXpTXXXXXAKKK, Thr = XXXXTXXXXXAKKK, pSQ =
XXXB(pS/pT)QJXXXAKKK, and SQ = XXXB(S/T)QJXXXAKKK. B. The optimal
motif of the tandem BRCTs of MCPH1. Bar graphs show the relative abundance
of each amino acid at a given cycle of sequencing compared to its abundance in
the starting peptide library mixture.
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Part 2: Characterization of a Novel Phosphopetide binding protein
PTIP
PTIP Background: The biological function of PTIP (Pax transactivation-domain
interacting protein) is relatively unknown. PTIP was initially identified in a yeast
two-hybrid screen using Pax2 as the bait [91, 92]. Pax2 is a paired box protein
with a defined role in the mesenchemyl to epithelial transition in the developing
kidney. To identify the biological function of PTIP, the Dressier group attempted
to generate a PTIP knockout mouse[93]. Instead of the expected Pax2-like
phenotype, the PTIP knockout mouse exhibited embryonic lethality at E9.5.
Murine Embryonic Fibroblasts (MEFs) derived from these embryos could not be
cultured in vitro. However, trophoblast cells were successfully cultured and
exhibited increased sensitivity to DNA damage. Because of the formation of
multiple double-strand breaks and the early embryonic lethality, both reminiscent
of the ATR, BRCA1, and Chk1 knockout phenotype[94], this study was the first
indication that PTIP may be involved in the DNA damage response.
The potential role of PTIP in the DNA damage response is further
supported by work done in the Yaffe lab by Isaac Manke[85]. He found that the
last two BRCT domains of PTIP functioned together as a phosphobinding module
that cannot only bind motifs generated by ATM and ATR but also pS-X-X-4 sites.
In addition, Manke et al found that PTIP interacts with 53BP1, a p53 interacting
protein that is thought to mediate interactions between ATM/ATR and its
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substrates in a phosphodependent manner [95, 96]. PTIP, like 53BP1, forms foci
after DNA damage, which are thought to represent the formation of multiprotein
repair complexes at sites of damage in response to IR.
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Figure 2-5: There are multiple splice variants of PTIP
A. Sequence alignment of the murine PTIP, 5BRCT-PTIP splice variant and the
6-BRCT PTIP splice variant. Order top to bottom, 5BRCT, 6BRCT, MankePTIP
B. schematic of the splicing scheme of the PTIP BRCT domains, the 5BRCT
domain form actually contains more exons at the N-terminus however, the start
site is disrupted due to a frameshift relative to the 6 BRCT form.
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Bioinformatic analysis of the PTIP coding sequence. Manke et al. performed
their studies with an N-terminally truncated form of PTIP that lacked the first two
BRCT domains (seq NM_007349.1) [85]. We quickly determined that this
coding sequence was truncated and we performed a thorough bioinformatics
analysis of the PTIP coding sequence. There are multiple splice variants of
PTIP. Significantly, two splice variants of PTIP have altered domain structure,
one splice variant that contains five BRCT domains, and another spliced variant
contains six BRCT domains. Because the splice variants use alternative starts
codons, the amino acid sequence of the N-terminal BRCT domains is different
(See Figure 2-5A and B). The 5 BRCT domain variant of PTIP is generated from
a longer mRNA transcript, however, there is a frameshift relative to the 6 BRCT
domain variant; much of the sequence is noncoding, and a downstream start
codon is used. The correct frame is restored at the C-terminus by another
alternative splicing event.
Because the protein used in Manke et al. did not correspond to the full-
length construct we first wanted to determine if full-length PTIP behaved in the
same manner as the N-terminal truncation. We obtained the full-length cDNA by
RT-PCR from U20S cells. The first experiment we performed was to determine
PTIP localization before and after DNA damage. Foci formation after ionizing
radiation is a hallmark of DNA damage proteins, and we specifically wanted to
determine if PTIP formed foci after DNA damage. As stated earlier, many DNA
damage proteins form foci after DNA damage. We transfected FLAG-tagged
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PTIP into U2-OS cells. We stained for ionizing radiation induced foci formation
before and after irradiation with 10Gy of IR. We found that the full-length
construct did form foci after ionizing radiation and these foci colocalized with pSQ
sites (Figure 2-6), which would have been generated from ATM phosphorylation
of DNA damage proteins on serine glutamine sites. In addition, in some
undamaged cells we observed PTIP foci. Although it may be that these cells are
in S-phase or undergoing a damage event, this seems unlikely as there were no
corresponding pSQ foci (data not shown). From these data we conclude that full-
length PTIP forms foci after ionizing radiation and may be involved in the DNA
damage response.
From the structure of the BRCA1 BRCT domains complexed with
phosphopeptide, two residues were identified that made direct hydrogen-bond
contacts with the phosphate of the phosphopeptide, Ser1655 and Lysl 702[86].
Mutations in these residues resulted in loss of phophopeptide binding function
and loss of foci formation of the BRCA1 BRCT domains. We performed a
sequence alignment of the PTIP and BRCA1 BRCT domains to identify the
corresponding residues in the PTIP BRCT domains of PTIP. The corresponding
residues of PTIP were T838 and K878. Mutation of these residues to T838A and
K878M resulted in abrogation of phosphopeptide binding of the PTIP BRCT
domains (Figure 2-7). Therefore the residues involved in phosphopeptide
binding activity of BRCA1 and PTIP are likely to be structurally conserved.
-IR +IR
FL-PTIP
pSQ
Merge
Figure 2-6: Full-length PTIP forms ionizing radiation induced foci after DNA
damage
Flag-tagged PTIP was transfected into U2-OS cells. After 24hrs, the cells were
irradiated and fixed 2hrs after irradiation. pSQ antibody was used as a marker for
foci formation. PTIP localized to the cytoplasm and nucleus before irradiation
and to nuclear foci after irradiation.
WT T838A K878M
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Fiqure 2-7:Conservation of Phosphopeptide binding Residues in PTIP
We performed a sequence alignment of the PTIP BRCT domains with the
BRCA1 BRCT domains; we predicted which residues were likely to form H-
bonding contacts with the phosphate of the phosphopeptide: T838 and K878.
Mutation of T838A and K878M abrogated phosphospecific binding. Libraries
used: pS = XXXXpSXXFXXAKKK, S = XXXXSXXFXXAKKK, pThr =
XXXXpTXXXXXAKKK, Phosphospecific binding was assessed as increased
binding to the pS library relative to the S library.
10% S pS 10%S 
pS 10% S pS
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We have established that PTIP is a phosphopeptide binding protein that
functions in a manner structurally similar to BRCA1 and forms foci after DNA
damage. We were next interested in generating reagents in order to do a more
in depth analysis of PTIP function including an antibody and a PTIP shRNA.
The first antibody we generated was to the C-terminus of PTIP. We chose
the C-terminus as the N-terminus of PTIP is alternatively spliced (Figure 2-5).
The amino acid sequence of this epitope was VLTQTLDYEAYKFN. We
performed many Western blots under many different lysis conditions in an
attempt to find a condition under which the antibody would detect the
endogenous protein. Transfection of tagged full-length protein was barely
detected; interestingly, the PTIP C-terminal BRCT domains were readily detected
by this antibody (Figure 2-8). However, endogenous PTIP was not detected by
this antibody; in addition the Flag-tagged full length and the BRCT domains of
PTIP were also transfected into cells, we found that even when we loaded the
same amount of protein, the PTIP antibody recognized the full-length protein
approximately ten-fold less efficiently than the C-terminal tandem BRCT domains
alone. The peptide that we used had a potential PTIP BRCT domain-binding site
VLTQTLDYEAYKFN. One likely reason that we could not detect endogenous
PTIP, despite the high immunoreactivity of the antibody to the peptide, may be
that PTIP is post-translationally modified at this epitope. However, phosphatase
treatment of lysates did not improve our ability to detect endogenous PTIP (data
not shown).
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Figure 2-8: PTIP antibody recognizes C-terminal BRCT domains of PTIP
Flag tagged BRCT domains 5 and 6 were transfected into U2-OS cells. The
lysates were incubated with different bleeds of the PTIP antibody as well as the
Flag antibody in order to determine if the the antibody we generated could detect
endogenous and transfected PTIP. We observed a band in the PTIP BRCT
transfected lanes that ran at the correct molecular weight.
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We generated a second antibody to PTIP to a GST-PTIP fusion (aal 98-
307 of 6BRCT domain PTIP). A larger antigen reduces the risk of the antigen
being modified or structurally inaccessible to the antibody in the context of the
full-length protein. This antibody recognized a band a the expected molecular
weight of endogenous PTIP. In addition, the PTIP antibody recognized a full-
length GFP fusion protein in transfected but not untransfected cells(Figure 2-9B).
From these data, we conclude that we generated an antibody that recognizes
PTIP.
Having generated a PTIP antibody, the next reagent we wanted to
generate was a PTIP shRNA. We co-transfected GFP-PTIP and and the PTIP
shRNA. We found that the band that migrated at the molecular weight we would
expect full-length PTIP to run did not get knocked down to a significant extent
(Figure 2-9B). In addition we found that co-transfecting RFP-PTIP with PTIP
shRNA 293T cells also resulted in a loss of RFP expression in the cells that
received the PTIP hairpin but not the negative control (Figure 2-9A). Therefore
we were observing knockdown of transfected PTIP using two different constructs,
however, we did not observed knockdown of endogenous PTIP.
The most likely hypothesis that would explain these data is that PTIP is a stable
protein. As we had cotransfected the plasmids that expressed recombinant
PTIP, we hypothesized that the recombinant protein was never expressed at any
appreciable level so that knocking down expression did not require any protein
turnover. In the case of the endogenous protein, however, observing a
knockdown by Western blot would require not only successful knockdown of the
mRNA levels but turnover of the endogenous protein that was expressed prior to
knockdown. In order to address this hypothesis, we decided to measure the
levels of mRNA directly. Using quantitative real time RT PCR, we found that
there was significant variability between the primer sets, but it was unlikely that
PTIP was being knocked down in U20S cells. The extreme stability of PTIP
cannot be the only reason that we did not observe PTIP knockdown, as we
generated several stable lines that expressed the PTIP shRNA. It is also likely
that PTIP knockdown cells are at significant selective disadvantage, and these
reasons in combination may explain why we were never able to obtain a PTIP
knockdown. As it was essential that we observe knockdown of PTIP protein, we
continued to attempt to knock PTIP down using different expression systems, cell
lines, and timepoints. However, we were unsuccessful at obtaining a robust
PTIP knockdown and therefore we determined that studying the budding yeast
homolog of PTIP, Esc4 would likely be a more fruitful venture. In conclusion, we
found that we could not complete this project for lack of reagents. We were
unable to obtain a knock-down for unknown reasons. We found that PTIP did
form foci after DNA damage. We also generated a PTIP mutant that failed to
bind phosphopeptides demonstrating the phosphobinding is structurally
conserved in BRCT domains.
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Ficure 2-9: Transfection of U2-OS cells with PTIP hairpins and a GFP
PTIP fusion causes efficient knock down of the transfected protein but not
endoqenous PTIP
A. We cotransfected a mRFP PTIP fusion and GFP vectors that expressed
control and PTIP targeted hairpins. We observed that RFP expression was lost
in the PTIP shRNA transfected cells (labeled "2" and "6"), but not in control
transfected cells (labeled "lucif"). Images were deliberately overexposed in the
red channel to ensure there was no RFP expression.
B. U2-OS cells were transfected with hairpins and a GFP-PTIP expressing
plasmid. Western blot was performed with affinity-purified PTIP antibody. We
observed a reduction in PTIP-GFP levels in the PTIP shRNA transfected cells but
not in the control transfected cells. In addition, we did not observe a reduction in
endogenous PTIP levels.
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C. Quantitative Real Time RT-PCR was performed on U2-OS cells infected with
lentivirus expressing a PTIP hairpin. We did not observe any consistent
differences between the PTIP shRNA and the control shRNA transfected cells.
Conclusions:
We identified two novel phosphopeptide binding proteins, MDC1 and
MCPH1. We found that these proteins require a free acid at the C-terminus for
robust phosphopeptide binding, and that neither MDC1 nor MCPH1 will bind to
phophopeptide libraries in which there are multiple lysines at the C-terminus.
MDC1 absolutely requires the presence of a C-terminal tyrosine in the +3
position (Figure 2-3)[42]. MCPH1 binding selectivity has not been completely
explored as of yet, but according to our data thus far, the BRCT domains of
MCPH1 require a free acid in the +3 position, in addition to having a preference
for tyrosine in the +3 position (Figure 2-3).
The structures of MDC1 and BRCA1 BRCT domains have been solved in
complex with phosphopeptide [42, 86]. Structurally, the residues involved in
phosphopeptide binding are fairly similar between the two BRCT domains
despite the differences in selectivity between MDC1 and BRCA1. The
phosphoserine binding pocket hydrogen bonds with the phosphate. There is a
conserved serine/threonine that hydrogen bonds with the phosphate and lysine
that forms a salt bridge. The +3 position is recognized by a hydrophobic pocket.
The M1775R mutation actually impedes the binding of an aromatic residue, as
the modeled phosphopeptide in the BRCA1 M1775R demonstrates that the
arginine would sterically clash with the pi cloud of the aromatic residue in the +3
position.
Over the course of the last six years there has been a fundamental
change in our molecular understanding of the way DNA damage signaling
proteins localize to a site of DNA damage. The first finding came from our lab
and others where we were able to show that a subset of tandem BRCT domains
function as a phosphopeptide binding module and that BRCT domains may be
recruited to sites of DNA damage through their interaction with ATM
substrates[85, 86]. This finding was further extended by work that we performed
in collaboration with the Jackson lab, where we found that the BRCT domains of
MDC1 interact with gamma-H2AX specifically[42].
With the data that is available to us now, we have a molecular
understanding of how proteins are recruited to sites of DNA damage. The early
events are MRN complex and ATM recruitment to sites of DNA damage. ATM
then phosphorylates C-terminus of H2AX. This results in the recruitment of
MDC1[42]. MDC1 is phosphorylated by ATM, which recruits RNF8 through its
FHA domain[71, 72]. RNF8 contains a RING Finger domain which ubiquitinates
H2A and H2AX. Ubiquitinated H2A and H2AX recruit Rap80 through its Ubiquitin
Interacting Motif (UIM) [71]. Rap80 interacts with Abraxas which interacts with
Brcal and recruits Brcal through its BRCT domains.
The role of PTIP in these processes is still unclear. With the
generation of inducible knockout cells by the Dressier lab, I expect that the
function of PTIP in the DNA damage response will soon be better understood.
PTIP contains six BRCT domains and therefore it seems likely that PTIP
functions as a scaffold. It still is highly likely the PTIP is an important player in
the DNA damage response.
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Methods:
IVT Peptide binding assay:
As in Manke et aL.2003, briefly: An oriented (pSer/pThr) phosphopeptide library
biased toward the Phospho-H2AX peptide was synthesized. Streptavidin beads
(Pierce, 75pmol/pL gel) were incubated with a ten-fold molar excess of each
biotinylated library in 50mM Tris/HCI (pH7.6), 150mM NaCI, 0.5% NP-40, 1 mM
EDTA, 2 mM DTT and washed five times with the same buffer to remove
unbound peptide. The bead-immobilized libraries (30pL of packed beads) were
added to 10pL of an in vitro translated [35S]-labeled protein pool in 150pL binding
buffer (50 mM Tris/HCI (pH7.6), 150 mM NaCI, 0.5% NP-40, 1mM EDTA, 2mM
DTT, 8pg/mL pepstatin, 8 pg/mL aprotinin, 8 pg/mL leupeptin, 800pM NaVO,, 25
mM NaF). Each 25uL IVT reaction was generated using 0.7pg plasmid DNA (TnT
in vitro expression cloning system Promega). After incubation at 40C for 3 hours,
the beads were washed three times 30sec 4000rpm 500pL with binding buffer.
Samples were boiled in 3X SDS-gel loading buffer and then subject to SDS-
PAGE (12%) and autoradiography. Positively scoring hits were identified as
protein bands that interacted more strongly with the phosphorylated immobilized
library than with the unphosphorylated peptide libraries.
Peptide Library Binding
Peptide library binding was done essentially as described (Yaffe and Cantley,
2000). For motif determination, a phosphoserine-oriented degenerate library of
sequence KKKYAXXXXpSXXX (X denotes all amino acids except Cys) was
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synthesized. Screening was done with saturating amounts of GST-MDC1 BRCT
(1-1.5 mg). Bound peptides were sequenced by automated Edman degradation
on a Procise protein microsequencer. Selectivity values for each residue were
determined by comparing the relative abundance (mole-percentage) of each
amino acid at a sequencing cycle in the recovered peptides to that of each amino
acid in the original library mixture at the same position (Yaffe and Cantley, 2000).
Mutations were generated using the Strategene QuikChange kit according to the
manufacturer's instructions. Mutations were sequence verified.
Immunofluorescence:
For immunofluorescence experiments, U20S cells were seeded onto 18 mm2
coverslips, irradiated or mock treated, fixed, extracted, and immunostained.
Cells were transfected using GeneJammer (Strategene) according to the
manufacturer's direction. 24-48 hours after transfection cells were either IR
treated with 10Gy or mock treated, cells were rinsed with ice cold PBS, and then
incubated with 20mM Hepes pH7.4, 100mMNaCI, 30mM MgCI2 , 10% sucrose,
0.5% Triton X-100 for 15min on ice to permeablize the cells. Cells were fixed in
3% (v/v) paraformaldehyde and 2% (w/v) sucrose for 10min at RT. Cells
were rinsed and then incubated with the antibody. The pSQ antibody was
obtained from Cell Signaling, the Flag-M2 antibody from Sigma. Zeiss Axioplan2
(Carl Zeiss) Microscope was used, OpenLab Software (Improvision) was used for
image capture. Coverslips were stained with primary antibodies at 37 "C for
20 min, then stained with a anti-mouse or anti-rabbit secondary antibody
for 20 min (Molecular Probes) at 37 OC. Primary antibodies used were
mouse anti-myc (Cell Signaling) and rabbit anti-(pSer/pThr)Gln (Cell
Signaling).
Real time RT PCR:
Was performed according to manufacturer's instructions. Applied Biosystems 2x
SYBR green kit was used. RNAesy (Qiagen) kit was used. RNA was extracted
according to the manufacturer's instructions.
Four micrograms of RNA were used for reverse transcription reactions with
specific primers for PTIP and TATA binding protein (TBP), which served as
an internal control: TBP RT primer 5'-
GTACATGAGAGCCATTACGTCGTC-3'; Rluc RT primer 5'-
GCATTCTAGTTGTGGTTTGTCC-3'. Reverse transcription was performed
using EndoFree RT (Ambion) according to manufacturer's guidelines.
Resulting cDNA was diluted 1/5 or 1/10 and either 1 or 4 pL of diluted
cDNA were subjected to real-time PCR. Each PCR reaction was measured
in quadruplicate. Real-time PCR was performed in a total volume of 25 pL,
using the SYBR Green Universal PCR Master Mix protocol according to
the manufacturer's instructions (Applied Biosystems). Relative mRNA
levels were determined using the 2-{Delta}{Delta}Ct method. mRNA
amounts were normalized to luciferase siRNA transfections. For detection
of Ago2 and Xrn1 mRNA levels, total RNA was harvested 48 h after
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transfection as previously described. Fifty nanograms of RNA were utilized
for reverse transcription reactions with random hexamers. Reverse
transcription was performed as previously described. One microliter of
resulting cDNA was subjected to real-time PCR using Syber Green primers
(SYBR). Each PCR reaction was measured in quadruplicate. TBP FP 5'-
GGAGAGTTCTGGGATTGTAC-3'; TBP RP 5'-
CTTATCCTCATGATTACCGCAG-3'. Real time was performed in a total
volume of 20 pL, using the SYBR Universal PCR Master Mix protocol
according to the manufacturer's instructions. Relative mRNA levels were
determined as previously described. Real-time reactions were conducted
in an ABI PRISM 7000 Sequence Detection System Thermal Cycler
(Applied Biosystems). PTIP Primers: Primer set 1F: 5'-
TTTCACTGGATTCGAGCCTGTCCA 1 R: 5'-CAC TT GCT GGC AAT GAG
GTG TGT 4F: 5'-TGA ATC ACA GCC AGC AGG GAC ATA 4R: 5'-AAG
GTT GCT GAG AGA TCT GCT GCT 5F: 5'-ACC CGC AGG TTA TTC
AGC TTC TCA 5R: 5'-ACA CTG AAC GGA CAG AAT CAC CCA 6F-
5'AAG GCA ATC GTA GAG TGT GCA GGA 6R: 5'-TCG AGT TCT GCT
TGT GCT CCA TGA
Chapter 3: The role of Esc4p in S-phase entry and the
budding yeast DNA damage response
Esc4p is the budding yeast homolog of PTIP. Here we show that loss of Esc4
results in premature S-phase entry, MMS sensitivity and increased translesion
polymerase activity.
We show that there is a modified form of PCNA present specifically in the escA
strains, and that Esc4p may interact with PCNA after MMS treatment. We find
that a subset of Esc4p interacting proteins exhibit an esc4A-like phenotype.
In addition, we show that the first four BRCT domains of Esc4 behave as an
acetyl-lysine binding domain in vitro.
Introduction: Esc4p in the DNA damage response:
Esc4 was initially identified in a screen for regulators of Tyl transposition. This
screen also identified physical interactors of Esc4p as well as members of the
DNA damage signaling pathway. The Tyl retrotransposon is present in
approximately thirty copies per Saccharomyces cerveisiae cell. While these
elements are thought to be tranpositionally competent, transposon events are
rare in most laboratory yeast strains. Inhibition of the Tyl transpostion can occur
at the level of transcription, translation or post-translationally. Mutations in Sgsl,
a RecQ helicase and Esc4 interacting protein, have been found to result in
increased Tyl mobility. Sgsl prevents the integration of reverse transcribed Tyl
elements into the genome. Genes identified in this screen were termed
regulators of Tyl transposition (RTT) [97].
To identify genes that prevent Tyl transposition, a strain was constructed
with an artificial Tyl element that contained HIS3 gene with an intron [97]. Upon
transcription of the Tyl element, the intron is spliced out, however, expression of
WT HIS3 does not occur until reintegration of the element as the intron is present
in the reverse direction. Only transcription of the Tyl element in its entirety,
reverse transcription of this transcript, and reintegration of the Tyl element
resulted in the expression of a WT His3p. Of the twenty-nine genes identified
that negatively regulate Tyl transposition, sixteen are genes that are clearly
involved in the DNA damage response. Of the sixteen involved in the DNA
damage response, four physically interact with Esc4p/Rttl07p, they are Rad57p,
Rttl09p, Rttl01p, and Sgslp.
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Esc4p/Rttl07p was also identified in a screen for regulators of silencing at
the mating-type locus [98]. A strain was created in which all three silencing
elements at the mating type locus (A, e, b) were replaced with the GAL4-UAS.
The GAL4-UAS element was driving a URA3 reporter gene. In the absence of
proper silencing, these strains expressed Ura3p, and are 5-FOA sensitive and
URA prototrophs; however in the presence of proper silencing, mediated by the
expression of a protein capable of silencing a locus, strains should be 5-FOA
resistant and require URA supplementation due to the silencing of the URA3
reporter gene. Esc4 (Enhanced Silencer of Chromatin) was identified in this
screen.
Esc4p contains six BRCT domains, and multiple SQ/TQ sites [98]. Mecl
and Tell are homologs of the human ATR and ATM respectively, and they are
known to preferentially phosphorylate serines and threonines followed by
glutamines. Rouse et al has shown that Western blot of immunopreciptated
Esc4 does react with a pSQ/pTQ antibody after DNA damage [99]. In addition,
Chin et al, demonstrated a phosphoshift in the Esc4p after DNA damage that
required the activity of both Mecl and Rad53 [100].
Esc4 physically interacts with a variety of proteins that are involved in the
DNA damage response. These include Mms22p, Rad55/57, RttlOl, Slx4, Sgsl,
and Sir3 (see Figure 3-5A). Mms22p is a protein with no known domains, whose
loss renders cells sensitive to DNA damaging agents such as MMS and
camptotheicin. The interaction between Esc4 and Mms22 was identified in a
high throughput mass spectrometry screen [101]. Rad55p/57p are members of
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the recombinosome complex involved in meiotic recombination. This complex
promotes strand exchange by the Rad51 recombinase. The interaction between
Esc4p and Rad55/57 was identified using yeast two-hybrid screen and the
interaction was confirmed using coimmunoprecipitation [100]. Rttll01p is a
ubiquitin-protein ligase that mediates replication fork progression through DNA
lesions or protein-DNA complexes. The interaction between Esc4p and Rttll01p
was identified using high throughput mass spectrometry. Interestingly, RttlO1p
also interacts with Mms22p, indicating that Rttll01p, Esc4 and Mms22p may be
in a complex [102] [101]. In addition, Rttl01 was identified in the same genetic
screen that Esc4 was initially identified [97]. SIx4 resides in a complex with SIx1.
The Six1/4 complex functions as a site-specific nuclease. The interaction
between Six4 and Esc4 was identified by mass spectrometry and confirmed by
coimmuniprecipitation [102, 103]. Sgs1p is a DNA helicase that suppresses
homologous recombination during DSB repair. The interaction between Sgslp
and Esc4p was identified in a yeast two-hybrid screen for Esc4 interacting
proteins [100]. Sir3p is a member of chromatin remodeling complex involved in
the silencing of mating type loci and telomeres [98]. The interaction of Sir3p and
Esc4p was identified in a yeast-two hybrid screen. In addition, there is a
functional interaction between Esc4p and Sir3p, as Esc4 mediated silencing of
the mating type locus in a one-hybrid screen discussed above depended on the
presence of Sir3p.
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Several groups have also reported that Esc4p relocalizes to chromatin
after DNA damage [100] [103]. More recently it was shown that after DNA
damage Esc4p relocalizes to chromatin in a manner that depends on both Rttl 01
and Rttl 09, a histone H3K53 acetyltransferase[102]. We are interested in
determining the molecular function of Esc4 in the DNA damage response; in
particular the function of the BRCT domains of Esc4.
Esc4 is the PTIP homolog:
The sequence conservation between Esc4 and PTIP is quite low.
However, the domain structure is nearly identical. The regions of sequence
homology can be mapped to regions that are predicted to have secondary
structure in a BRCT domain (Figure 3-1). Esc4 is the only protein in budding
yeast that contains six BRCT domains; PTIP is only one protein in metazoans
that contains six BRCT domains. Esc4 is the closest yeast homolog to PTIP
using BLAST; in addition, PTIP is the best BLAST hit for Esc4. We were
interested in assessing the function of PTIP in mammalian cells, however, after
encountering significant hurdles we chose to study the yeast homolog of PTIP
called Esc4p.
Budding yeast is an ideal system to perform these experiments, not only
because it is a genetically tractable eukaryotic system, but because of the
significantly smaller genome in budding yeast, there is less of a dependency on
DNA repair/signaling machinery to replicate the genome. This might allow us to
avoid the hurdles we encountered with the presumed lethality of PTIP
knockdown cell lines.
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Fiqure 3-1: Sequence conservation of PTIP and Esc4: The protein
sequences of Esc4 and PTIP were aligned. Most regions of homology
are at sites of secondary structure ***=regions of sequence homology
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Results/Discussion:
As we hypothesized that PTIP was involved in DNA damage signaling or
DNA repair, we first performed experiments to determine the sensitivity of esc4A
to Methylmethanesulfonate (MMS). MMS is a monofunctional alkylating agent,
that preferentially modifies purines. The most common adducts are 7-
methylguanine (83%) and 3-methyladenine (11%). In addition the alkylated
bases have a weaker N-glycosyl bond resulting in spontaneous hydrolysis and
the generation of apurinic sites. Typically, MMS is thought to cause an S-phase
accumulation and/or arrest, as these lesions, particularly 3-methylAde
modifications, result in replication blockage. 7-methylguanine and 3-
methyladenine are either repaired by Base Excision Repair, the glycosylase
Mag-1 being the key enzyme in the process, or bypassed by a translesion
polymerase. A typical dose of MMS that is used is in liquid cultures is 0.015%,
this results in an initial S-phase accumulation and an eventual release. This
release is delayed in DNA damage mutants such as meclAATR. Therefore the
first experiments we performed were to assess the cell cycle profile of esc4A
after MMS treatment. We used several different concentrations of MMS: 0%
(untreated), 0.0015% MMS, 0.015% MMS, and 0.03% MMS. In addition to
determining the cell cycle profile of esc4A after MMS, we assessed the
sensitivity of esc4A to MMS by growing esc4A on YPD plates containing different
concentrations of MMS. We then counted the colonies and normalized the
number of colonies to the untreated plates.
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Figure 3-2: esc4A are MMS sensitive, and exhibit at G2/M arrest after low-
dose MMS treatment.
A. WT and esc4A were treated with the indicated concentrations of MMS and
collected at one hour and three hours after treatment. X-axis indicates DNA
concentration. Cell cycle FACs demonstrates a 2n accumulation in the
esc4A after low-dose DNA damage.
B. Strains were generated to assess the MMS sensitivity of esc4A during
chronic MMS treatment on MMS containing plates. The concentration of
MMS is on the X-axis. Cells were grown to log-phase and then plated on
fresh YPD plates containing the indicated dose of MMS. These data were
normalized to the number of colonies on an undamaged plate. Strain
numbers #4, #5, #7 indicates three independent transformants of esc4A. All
three esc4A strains failed to grow at 0.01% MMS, whereas the VVT strain had
approximately 50% viability at this dose.
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The undamaged asynchronous cell cycle profile of esc4A is not grossly
different from WT (Figure 3-2A). There is a dose-dependent cell cycle
perturbation in the esc4A. At the lowest dose of MMS, we observe the most
extreme phenotype, and at the highest dose of MMS, the esc4A phenotype is
indistinguishable from WT. We observed a delay in release from MMS treatment
at the 0.015%MMS dose in the esc4A. Interestingly, at an extremely low-dose of
MMS (a dose ten-fold lower than typically used in the literature), we observed a
striking difference between the esc4A and WT strains. Whereas the WT strain
did not arrest at the low dose of MMS, esc4A, have a long-term arrest in G2/M.
esc4A also exhibit MMS sensitivity on a plating assay (Figure 3-2B). The esc4A
fail to grow on a dose of MMS that five-fold (0.01% vs 0.05%) lower than a dose
that prohibited growth of WT cells.
We were next interested in determining the actual point in the cell cycle
that esc4A were accumulating after low-dose damage. We stained cells with a-
tubulin and looked at spindles morphology. We found that esc4A arrested in
metaphase after low-dose DNA damage (Figure 3-3C).
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Figure 3-3: esc4A exhibit a metaphase arrest after DNA damaae that requires
Rad9p
A. Cells were treated 0.0015% MMS and collected at Ohr and 3.5hrs. Cell cycle
FACs demonstrates a 2n accumulation in the esc4A and esc4AmadlA after
low-dose DNA damage but slightly less 2n accumulation in esc4Arad9A. This
indicates that the 2n accumulation in the esc4A is at least partially due to the
DNA damage response
B. Cells with wild-type Esc4 do not exhibit a 2n accumulation regardless of
background. Strains were treated as above.
C. esc4A and esc4AmadlA but not esc4Arad9A exhibit a metaphase arrest after
DNA damage. This indicates that the metaphase arrest observed in esc4A is
due to the DNA damage response, as loss of rad9A and therefore the DNA
damage checkpoint bypasses the metaphase arrest in esc4A
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We established that esc4A arrested in metaphase after DNA damage, the next
question we asked was what signals resulted in this arrest? Unlike mammalian
cells, where the spindle checkpoint and the DNA damage checkpoint target
different proteins and different phases of the cell cycle, the yeast DNA damage
checkpoint and the DNA damage checkpoint coalesce onto the same protein,
Pdslpsecurin (see Figure 1-2). Securin binds to and inhibits separase, the
enzyme responsible for cleaving cohesion, the protein complex joining two sister
chromatids. Once separase is activated by the degradation of securin, the
metaphase to anaphase transition occurs. In yeast, securin is phosphorylated
and stabilized by both the DNA damage checkpoint and the spindle checkpoint.
Therefore, we asked the question, which checkpoint pathway is activated in
esc4A after MMS treatment? In order to answer this question, we generated
several esc4A double mutants. The first was an esc4A rad9A. Rad9p is tandem
BRCT domain containing protein that is an important component of the DNA
damage pathway as it mediates Meclp phosphorylation of Rad53p. Loss of
Rad9, results in a loss of DNA damage dependent checkpoints. If the
metaphase arrest in esc4A was due to a DNA damage dependent event, then the
esc4A rad9A double mutant is likely to resemble the rad9A phenotype, which
does not arrest in metaphase after in low-dose MMS treatment. In order to test
the possibility that the metaphase arrest was due to the activation of the spindle
checkpoint, we generated esc4A madlA double mutant strains. Mad1 is an
essential component of the spindle checkpoint. If the esc4A metaphase arrest is
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due to the spindle checkpoint then the esc4A madlA strain should fail to arrest
after MMS treatment. We found that the esc4A rad9A strain bypassed the
metaphase arrest we observed in esc4A after low-dose MMS. Conversely, the
esc4A madlA strain failed to bypass the metaphase arrest. We therefore
conclude that the metaphase arrest is due to the activation of the DNA damage
response, which presumably stabilizes Pdslp, thereby preventing entry into
metaphase (Figure 3-3C).
The next question we asked is why is the DNA damage response
persistently activated? It could either be due to failure to exit the checkpoint or
incomplete repair. In order to address this question we first looked at the maglA
strain. Maglp is a glyocolase responsible for removing methylated bases.
Without Mag1p activity, MMS lesions cannot be repaired using BER, and they
must be repaired using TLS activity exclusively. As we showed in Figure 3-3A,
the cell cycle profile of the rad9A is indistinguishable from the cell cycle profile of
WT cells after low dose MMS treatment. Although rad9A cannot activate DNA
damage checkpoints we cannot assume that DNA repair per se is impaired.
However, it was unclear from these data whether the reason for similarity in the
WT and rad9A phenotypes was due to the possibility that rad9A do repair the
damaged DNA, or that at such a low-dose of MMS, a failure to repair DNA
damage does not provide such a significant barrier to DNA replication,
transcription, etc, that a yeast cell can effectively tolerate the number of adducts.
In order to gain insight into this issue, we determined the cell cycle profile of the
maglA strain. We found that maglA have a G2/M arrest that is similar to esc4A
(Figure 3-4B). This indicates that the dose of MMS we are exposing these strains
is sufficient to generate a checkpoint if there is a repair failure, and that the
checkpoint is induced in metaphase not in S-phase, unlike higher doses of MMS.
This is an interesting observation, because it is clear from these data that a
barrier to replication may not be the reason for the checkpoint activation in these
strains, because replication barriers would likely cause an S-phase arrest.
Having established that there is likely a repair defect in esc4z, we were
interested in determining if the repair defect involved other types of damaging
agents in order to provide insight into the source of this defect. We used cisplatin
which, is a bifunctional alkylating agent that causes intrastrand crosslinks,
doxorubicin is a Topo II inhibitor which causes double strand breaks,
camptothecin, a Topo I inhibitor which causes single strand breaks, and HU,
ribonucleotide reductase inhibitor, which results in a depletion of dNTPs and
replication fork stalling. We found esc4A arrest in G2/M after treatment with all
the agents except HU (Figure 3-4A). Since HU is the only agent that does not
cause a physical lesion, these data are interesting, and consistent with the model
that esc4A are impaired in DNA repair (Figure 3-4A). However, an important
caveat to these data is that the asynchronous profile of the undamaged WT and
esc4A are fundamentally different in this experiment, therefore the differences in
the profiles after DNA damage may be due to a cell cycle difference rather than
an inherent sensitivity of esc4A.
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Figure 3-4: esc4A arrest in G2/M after treatment with a variety of DNA
damaqing agents
A. Cells were treated with the indicated concentrations of damaging agents and
collected at several timepoints. Cell cycle FACs demonstrates a 2n
accumulation in the esc4A treatment with a variety of DNA damaging
agents.HU=hydroxyurea, Dox=doxorubicin, MMS.
B. maglA exhibit a severe accumulation in G2/M after MMS treatment. Red
indicates damaged cells, blue is the undamaged control.
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In support of the hypothesis that esc4A is impaired in DNA repair, several
Esc4p-interacting proteins are DNA repair proteins. (Figure 3-5A) We were
interested in determining the phenotype of Esc4p-interacting proteins deletion
strains after low-dose MMS treatment. We obtained deletions from the deletion
collection, and determined the cell cycle arrest of these strains in response to
low-dose MMS. We found that rtt101A, and mms22A have phenotypes similar
(Figure 3-5B) to esc4A. This is particularly interesting because Rttl01p, Mms22p
and Rttl 07p were found to interact with each other in a mass spectrometry
screen; they are thought to exist in a complex. Therefore these three proteins
may be acting together to mediate DNA repair. sIx4A also had a similar
phenotype in early timepoints, as slx4A initially accumulated in G2/M; however,
at later timepoints slx4A cell cycle profile more closely resembled the WT cell
cycle profile. This is consistent with the idea that Esc4p may be acting as a
scaffold. If this were the case, mutations in or the loss of individual proteins that
Esc4 would be recruiting to sites of DNA damage would be expected to have a
less severe phenotype, as the esc4A phenotype would be additive of all the
proteins that fail to be localized properly in the absence of Esc4p. These data
also implicate Esc4 in DNA repair.
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To determine where the repair defects were in the esc4A, we first took
advantage of an assay utilized in the Walker lab that measures error rate in our
strains. Cells are grown to saturation in minimal media so that they accumulate in
G1/GO. This prevents repair via homologous recombination, as homologous
recombination requires a sister chromatid. We generated esc4A in the W1588
strain, which contains an ochre mutation in the ade2 gene, rendering these
strains adenine auxotrophs. In addition, this strain is WT for RAD5, a key DNA
damage protein that is mutated in W303. We damaged WT and esc4A with
MMS or UV and measure the number of revertants by plating cells on adenine
deficient media and counting the colonies that grew in the dark. These colonies
are generated through error-prone translesion polymerase activity. This assay
quantitatively measures errors in repair in the esc4A. esc4A both basally and
after damage have increased error-prone repair (Figure 3-6 A). While there is a
statistically significant increase in the number of colonies able to grow on
adenine deficient media in esc4A after MMS treatment (Figure 3-6B), these data
are more impressive after UV treatment, as esc4A have 30% more colonies than
WT. In addition, the relative difference in colonies after UV treatment is dramatic
after DNA damage. This is likely is because the lesion induced by UV treatment
is more amenable to generating a reversion mutation from an ochre mutation.
For both these assays we chose doses of UV irradiation and MMS that provided
no survival disadvantage relative to WT controls (Figure 3-6C, Figure 3-2B)
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Figure 3-6: esc4A Exhibit Increased Error Rate
A. esc4A exhibit increased error rate after UV treatment. Strains were grown
into stationary phase and cells were plated on minimal media -ade or +ade
and subject to UV irradiation at 40JIm2 ,colonies able to grow on an Ade-
plate were quantitated and normalized to the number of colonies on the Ade-
plate. Cells were kept in the dark after UV irradiation in order to prevent
direct repair through a photo-dependent mechanism. The data is the
average of the three independent transformants.
B. esc4A are not UV sensitive. Number of colony forming units after UV dose
in esc4A and WT cells. Cells were grown to log phase, plated on minimal
media and irradiated at varying doses of UV. Number of colonies was
quantitated and normalized to the number of colonies on the undamaged
plate. esc4A exhibited a similar survival rate as the VVT.
C. esc4A exhibit increased error rate. Three independent transformants were
grown as (A), except the strains were grown on 0.001% MMS plates or
control plates. Numbers indicate independent transformants of esc4A.
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Because we observed in error rate in esc4A, and a known Esc4p-
interacting protein is a cullin, we hypothesized that Esc4 might affect PCNA post-
translational modifications. PCNA is the processivity clamp, that maintains the
association of DNA polymerases with DNA. PCNA is modified after DNA
damage and these modifications regulate how DNA repair is mediated. PCNA
can be modified on either K164 or K127 residues. The K127 is exclusively
SUMO-modified. However, the K164 residue can be either mono-ubiquitinated,
poly-ubiqutinylated or SUMO-modified. Mono-ubiquitination is thought to
promote translesion polymerase activity, poly-ubquitination promotes error-free
repair, and SUMO-modifications represses repair. Interestingly the poly-
ubiquitin chains are K64 linkages, rather than the typical K48 linkages which
mark for proteosomal degradation. Since esc4A cells had increased error rate
and Esc4 interacts with a cullin, we hypothesized that esc4A might have
increased mono-Ubiquitinated PCNA. We obtained a strain from the D'Andrea
Lab, which contained a pol30A in addition to carrying a plasmid which expressed
His-tagged pol30 off the pol30 promotor. We generated an esc4A in this strain.
In addition to the esc4A we compared PCNA post-translational modifications to a
rad18A obtained from the D'Andrea lab. Rad18 is the E3-ligase which
ubiquitinates PCNA. We initially performed experiments under MMS conditions.
At both high and low MMS we failed to observe any difference between the
esc4A and WT strains (Figure 3-7A, B). However, after UV treatment, we
observed a band that is specifically generated in the esc4A strains (Figure 3-
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7C). This band, which corresponds to 50kDa, did run at the expected molecular
weight for mono-ubiquitinated PCNA. We hypothesize that this band may
correspond to SUMO-modified PCNA. We are currently testing this hypothesis
by deleting Siz1 in the esc4A and we will use these strains to look both at PCNA
post-translational modifications and translesion polymerase activity. This is an
especially satisfying hypothesis because increased SUMO-modified PCNA
contributes to error-prone repair, which is consistent with the increase error rate
we observed in the esc4A. If the increased error rate is due to increased SUMO-
modified PCNA, we expect there to be a reduction in the mutation rate in esc4A
siziA relative to the esc4A alone.
Because the Esc4 protein sequence contains two motifs that have been
identified to be PCNA consensus motifs, we hypothesized that Esc4p may
interact with PCNA. Using Tap-tagged strains, we affinity purified Esc4 in HU-
treated cells, asynchronous cells or MMS treated cells. We found that Esc4p
specifically interacts with PCNA after DNA damage (Figure 3-10), but not in
asynchronous and HU synchronized cells.
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Figure 3-7: esc4A exhibit a specific modification of PCNA after UV
treatment
A. esc4A do not exhibit a difference in PCNA modifications after normal-dose
MMS treatment of 0.03% at RT for 3hrs. His-tagged PCNA was expressed
from the endogenous promotor purified on nickel-NTA beads subject to
SDS-PAGE, transferred onto PVDF and blotted with a PCNA antibody. The
band at 28kDa corresponds to unmodified PCNA, bands that are present in
damaged cells but not in the radl8A are presumably ubiquitin-modified
forms of PCNA.
B. esc4A do not exhibit any difference in PCNA modifications after low-dose
MMS treatment of 0.0015%. Same as in A, except at a lower dose of MMS.
C. esc4A do exhibit a modified form of PCNA that is not present in the WT after
UV treatment. Same as above, except cells were collected by
centrifugation, resuspended in PBS put in Petri dishes and UV irradiated
with shaking. Cells were collected and placed in YPD and allowed to
recover at RT for 3hrs.
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The role of Esc4 in an Unpreturbed Cell Cycle:
In order to assess the role of Esc4 in the cell cycle we synchronized esc4A cells
by both alpha-factor and elutriation. Using both techniques we found that there
was a similar effect; esc4A entered S-phase earlier than the VVT counterpart.
The esc4A entered into S-phase about twenty minutes earlier than WT according
to the FACS cell cycle profile (Figure 3-8A). In addition, the number of budded
cells was higher in the escA relative to the WT control. We also noted that the
time for replication was longer in the escA than in the WT cells, as there were
cells in S-phase for four time points rather than three in the VVT (Figure 3-8A).
In addition, post-elutriation, esc4A bud earlier than the WVVT, consistent with
esc4A entering the cell cycle earlier than the WT (Figure 3-8B). We measured
cell volume in order to ensure that the early S-phase entry was not due to a more
rapid cell growth in the esc4A. The esc4A are the same size as the WT (Figure 3-
8C), therefore it is unlikely that the early S-phase entry was due to rapid growth
of the esc4A.
The timing of S-phase entry is regulated by a number of factors. One of
them is the HDAC Rpd3 [60]. Rpd3 is thought to directly regulate origin firing by
regulating histone acetylation. In addition [102], recently, it has been shown
that Esc4p is recruited to chromatin after DNA damage in a manner that depends
on the HAT Rttl09. We had previously determined that the BRCT domains of
Esc4 did not bind phosphopeptides (Figure 3-9A). We screened for acetylK
specific binding of the Esc4 BRCT domains. We found that Esc4 BRCT domains
1-4 behave as an acetylK binding domain (Figure 3-9B).
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Figure 3-8: esc4A exhibit a precocious S-phase entry
A. esc4A enter into S-phase earlier than the WT control. Cells were collected
by elutriation, allowed to grow for 1.5hrs at RT, fixed in 70% EtOH, and
collected every 20min for cell cycle FACs analysis. Cells were stained with
SYTOX green (Molecular Probes). The most significant differences are
observed at the 60min and 80min timepoints.
B. esc4A bud earlier than the WT control. Cells were collected by elutriation,
allowed to grow for 1.5hrs at RT, fixed in formaldehyde. 100 cells were
counted for every sample. Volume was determined by using flow cytometry
on live cells.
101
Esc4 BRCT
1-6 1-4
10% S pS 10% S pS
Esc4 BRCT
PIkl PBD 5-6 3-4
10% S pS 10% S pS 10% S pS
Esc4 BRCT 1-4
10% K AcK
Figure 3-9: Esc4p BRCT domains do not bind phosphopeptides but do
bind acetylated peptides
A. Esc4 BRCT domains were in vitro translated in the presence of 35-S
methionine incubated with either phosphoSXXF library or SXXF library, the
budding yeast Rad9 was used as a negative control and human Plk1 was
used as a positive control. All Esc4 constructs failed to bind in a
phosphospecific manner. Constructs labeled with numbers indicate BRCT
domains: 1-6=BRCT domains 1-6, 1-4=BRCT domains 1-4, 5-6=BRCT
domains 5-6, 3-4=BRCT domains 3-4.
B. Esc4 BRCT domains 1-4 were in vitro translated in the presence of 35-S
methionine incubated with either an acetylK or K library. There was
increased binding of the Esc4 BRCT domains to the AcK library.
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ESC4 protein sequence
MSTSLLFEQLNFLILVAAEAELPIAHSTRKLLMDNSCNNCQIYELYNENLKDVKTDKDWF
MNKFGPQTVHFVISNTINFPFYKIVYFDLLIPVVMPSHTVMTQDSVKTKRHLRTNMYSPNPFH
LLRDCQVYISKSSFNKCEYILYSDLLHLLGGTLVNY|SNRTTHVIVQSPQDPIIATVSKL
TFGSFSSSSTNKHTEKPLREWKFVYPIWILYHFKMAKPLKGELATLCELDMQDTSEEQLF
AKWEEVIGDKQTSSSQLTLHPNKTLFKNHHFAISPDLNFFTPLYWFLKGFIEDLDGKVTP
LSFSDDLKSVYQAFPDIDCYIGHSANSPILEKTKSIKPEIHVGNVSWLFYMFALQKFTPV
SQCKLIHQPFHAKLFTSKELTVAYTNYFGSQRFYIQRLVEILGGLSTPELTRKNTHLITK
STIGKKFKVAKKWSLDPQNAIIVTN HMWLEQCYMNNSKLNPKDSRFQNFKLDDNMGWNIG
QIGMDHSSLPTPKNLSMVTYDTQSISEKPPPTNDQMDQINDNTNVLSKKDGTPISSFENS
IDEKIDKLQKISGEVAVTHSGDLERSFVSRPSRASFPVVDSKKSNLQKKDSNSDISMETE
VFCEGHEKREEKEFTKPITEYDAPKKQEIREQSRKKNDIDYKKEEEETELQVQLGQRTKR
EIKTSKKNEKEKETNECHIEVDQMTNEKQGEESTGKLISTEDVTSKKDTDKFSHLFEGLS
DNDDHINDEKPAVNSKYTTPKTSQNITSGVDTPTTAQTQVFMPSSGNSRLAKTQAAKRLH
TDIESLN EFQKNFKRKRIDSEEISLSQDVERSNNNKELATKAEKILARFNELPNYDLKAV
CTGCFHDGFNEVDIEILNQLG iKI FDNIKETDKLNCIFAPKILRTEKFLKSLSFEPLKFA
LKPEFIIDLLKQIHSKKDKLSQINI NLFDYEINGINESIISKTKLPTKVFERANIRCINL
VNDIPGGVDTIGSVLKAHGIEKINVLRSKKCTFEDIIPNDVSKQENGGIFKYVLIVTKAS
QVKKFTKLINDRDKNETI LIVEWNWCVESIFHLNVDFTSKKNVLYQKKNN
PCNA interaction Motif:
QXX(M/L/I)XX(F/Y)(F/Y)
Fiqure 3-10: Esc4p may interact with PCNA after DNA damage
A. TAP-tagged Esc4 strains were treated with low-dose MMS, HU, or left
untreated for 3hrs at RT. Lysates were generated and incubated with
Protein A beads. Coimmunpreciptiation of PCNA was detected using an
endogenous PCNA antibody. WT strains were used as a negative control.
PCNA was specifically pulled down in the cells that were treated with low-
dose MMS.
B. Esc4p contains two PIP boxes that may mediate the PCNA Esc4 interaction.
The Esc4 protein sequence was retrieved and scanned for PIP boxes.
Potential PIP boxes are highlighted in yellow. PIP box residues are in red.
The PIP box motif is QXX(M/L/I)XX(F/Y)(F/Y) where X is any amino acid.
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Conclusions:
My data point to a model whereby Esc4p recruits DNA repair machinery to
sites of DNA damage. It is likely that the underlying defect in esc4A is a DNA
repair defect. We find that esc4A have increased error rate, however we
suspect this increased activity is due to an increase in SUMO-modified PCNA. A
reduction in SUMO modifications can result in a reduction in errors. Therefore
the increase in errors in esc4A strains could be due to this increase.
What is particularly intriguing but as of yet unclear in this study is the
reasons for the metaphase arrest specifically after low-dose MMS treatment. 3-
methyladenine lesions are thought to be the lesions that cause replication
defects. It may be that at low doses of MMS there is are very few 3-
methyladenine lesions and therefore it is the other lesions that result in the
metaphase arrest.
We have several models for Esc4 function. The first is that Esc4 is a
scaffold (Figure 3-11). This model is supported by the fact that Esc4 contains
several BRCT domains and that Esc4 interacts with a variety of DNA repair
proteins. We hypothesize that Esc4 may act as a DNA repair toolbelt, that is
recruited to sites of DNA damage presumably by a subset of its BRCT domains.
Esc4p then would recruit DNA repair proteins, and then the DNA repair proteins
with their inherit specificity would mediate repair.
The second model is that Esc4 represses PCNA SUMO-modifications.
This model would be consistent with the increased error rate in esc4A and the
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presence of a band in esc4A that may correspond to SUMO-modified PCNA
(Figure 3-12).
One of our most interesting findings is that Esc4p may act as an acetyK
binding protein. This would constitute a completely novel binding function for a
BRCT domain. Identifying an Esc4p ligand is a very important next step. We
have initiated some studies in order to find an Esc4 ligand, both a hypothesis
driven approach using predicted histone peptide sequences and a screening
strategies. It is most likely that Esc4 binds to a histone modification that is
generated after DNA damage. The elegance of the conservation of BRCT
domains binding to histone modifications throughout evolution would be
satisfying. Despite not being a phosphopeptide binding protein, Esc4 may still
function in binding to a histone modification, much like MDC1 and MCPH1 bind
to histone modifications.
Overall this work is highly consistent with the idea that BRCT domains are
fundamentally important in the DNA damage response. They function like
molecular building blocks, aiding in making the connections between damaged
DNA and DNA damage signaling and DNA repair.
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Esc4p
Fiqure 3-11: Esc4p may function as a scaffold
Esc4p interacts with many different DNA repair proteins. It has been reported in
the literature that Esc4p is recruited to chromatin after DNA damage. It may be
the case that Esc4p is recruiting these repair proteins to sites of DNA damage.
We would postulate that Esc4 is recruited to sites of DNA damage through a
chromatin modification, and Esc4 would recruit DNA repair proteins through
different BRCT domains. Esc4 may also be recruited to DNA lesions during DNA
replications.
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Fiqure 3-12: Esc4p may repress Sumo modifications of PCNA
It consistent with our data that Esc4p may repress SUMO modifications of PCNA
and thereby promote homologous recombination. Reduced SUMO modified
PCNA would result in increased Ubquitinated PCNA and promote error-free
repair.
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Chapter 3 Methods:
Yeast cells were grown overnight to an OD600 between 0.2 and 1 in YPD at
300 C. They were diluted in the morning to an OD600 of 0.2. Cells were then
damaged or left undamaged. MMS was diluted fresh to generate a 1% solution
in YPD and the appropriate amount of damaging agent was added to generate
0% MMS, 0.0015% MMS, 0.015% MMS, or 0.03% MMS final concentration.
Liquid cultures were grown at 300C and 1mL aliquots were collected and fixed in
cold 70% EtOH for FACs or 3.7%formaldehyde in 0.1M potassium phosphate pH
6.4 for spindles.
For cell cycle FACS staining, cells were spun down at 3000rpm and resuspended
in 500uL 50mM Na citrate pH 7.6and 12.5uL of 20mg/mL boiled RNAse A. The
samples were incubated at 500C water bath for 1 hr (water bath was better than
heat block). Samples where then sonicated for a 5sec continuous pulse at
setting 3. Samples were then centrifuged at 3000rpm for 30sec and resuspended
in 500uL 50mM Na citrate pH 7.6 to which 500uL of a stock of 1:1000 Sytox
Green was added (Molecular probes). Samples were incubated at RT for 30min
in the dark. Signal was detected using the Becton Dickenson FacScan machine
and data were analyzed using FlowJo (http://www.flowjo.com/).
For spindles, we used followed standard protocols used by the Amon Lab.
Briefly, we digested cells in glusolase/zymolyase. Cells were immobilized on a
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silde using 0.1% polylysine. Cells were fixed in MeOH for 3min, followed by
acetone for 30sec. Slides were incubated with rat alpha tubulin for 1hr and
washed five times with PBS/BSA. After incubation with rat-FITC secondary
antibody for one hour, washed and DAPI-Mounted.
TLS assay: Cells were grown in SC-glucose for 2days at 30C. Cultures were
diluted 10,000 fold, plated on SC-complete/glucose or SC-Ade-/glucose. For
plating on the Ade-plates, 2mLs of culture resuspended in 215uL, 100uL was
plated on the unirradiated plate, and the other 100uL was plated on the irradiated
plate. Cells were irradiated on the plates with a UV lamp emitting at 254nm. The
dose rate was determined before each assay using a dosimeter.
PCNA IP: Cells were grown in MMS, HU or left undamaged for 2hrs at RT. Cell
pellets were resuspended in 0.4 ml of lysis buffer (50 mM HEPES pH 8.0,
140 mM NaCI, 1 mM EDTA and 1% Triton X-100, with a final concentration of
protease inhibitors: 300 pg/ml benzamidine, 1 pg/ml pepstatin, 2 pg/ml antipain,
0.5 pg/ml leupeptin, and were lysed by vortexing with glass beads at 40C in a
FastPrep Machine. The supernatant was removed to clean tubes, and the
resulting lysate was incubated with anti-lgG beads overnight. Beads were
washed and eluted in 3X-SDS PAGE buffer.
PCNA-PTM assay:
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Cells were collected after damage for 2-4hrs at 300C. Cells were lysed on ice in
500uL of NaOH/2-ME solution for 10min. 500uL 50% TCA was added, lysate
was allowed to precipitate for 15min on ice. After spinning down at 13krpm for
15min, pellets were washed 500uL of acetone, and resuspended in 10OmMTris
pH8, 6M Guanadine-HCI by rocking for 1 hr on a wheel. Lysate was centrifuged
15min 13krpm for 20min. The supernatant was incubated with Nickel-NTA beads
(Qiagen) for 2hrs at RT. Imidazole was added to a final concentration of 20mM.
Beads were washed twice with 1mL Guanidine and two times in 1mL RIPA
buffer. Proteins were eluted by incubation lysates in 200mM Imidazole for 20min
at 40C.
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Chapter 4: Future Work/Conclusions
111
It is important to understand the function of Esc4 in the DNA damage response
on a more mechanistic level. There are a few questions about Esc4 function that
are essential to answer. The first question is what is the modified form of PCNA
in esc4A cells? We are currently trying to address this question by generating
esc4A sizlA double mutant strains. We will use these strains to determine if the
modified PCNA is, in fact, SUMO-modified. Siz1 is the SUMO-ligase in budding
yeast that is known to modify PCNA; therefore if PCNA is SUMO modified in
esc4A through typical pathways, this modification should be lost in the sizIA. In
addition, there should be a reduction in TLS activity in the esc4AsizlA. Other
groups have shown that combining rad18A siziA suppresses the rad18A
phenotype because part of the rad18A phenotype is due to excessive SUMO-
modification of PCNA which is relieved by siz1 loss.
Because the PCNA-Esc4 interaction that we detect is less than
convincing, we have attempted to generate PIP box deletions. We have thus far
been unable to generate the construct, but this construct is essential for
bolstering the functional relevance of PCNA-Esc4 interaction data. If Esc4p
does interact with PCNA, ideally deletion of the PIP box would abrogate this
interaction; in addition, a phenotype associated with this mutant would be an
important addition to our argument that Esc4p and PCNA interact in a biologically
functional manner.
It is also important to address whether Esc4 acts as a DNA damage
scaffold. Because Esc4 interacts with several DNA damage proteins,
determining how Esc4 functions with these proteins is essential to understanding
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Esc4 function. We have begun to generate strains in WT and esc4A
backgrounds that also express GFP-tagged Esc4-interacting proteins. We plan to
test our hypothesis that Esc4 is a scaffold for DNA repair proteins with these
strains by determining whether Esc4-interacting proteins are able to localize to
chromatin after DNA damage in an Esc4-dependent manner. In a more
sophisticated study, we would like to mutate individual BRCT domains of Esc4 in
order to determine which BRCT domains are required for Esc4 localization to foci
and which BRCT domains are required for localization of Esc4-interacting
proteins. Esc4-interacting proteins may localize via distinct domains or in a more
competitive manner through the same portion of the protein.
A key set of studies will seek to identify acetyl-lysine specific ligands of
Esc4p. It has already been shown in yeast that histones are acetylated and then
deacetylated after DNA damage. Because Esc4p is already known to interact
with Sir3p and function with Sir3 in an artificial setting, it is worthwhile to
determine if histone deacetylation is abrogated after DNA damage in the
absence of Esc4p. It is possible that Esc4p could be recruited to sites of DNA
damage by the HAT activity of Rttl09, and it may first recruit the DNA repair
machinery while the chromatin is open. I hypothesize that once the DNA is
repaired, Rtt109 would dissociate from the chromatin, and the HDACs that
interact with Esc4 could dominate, returning the chromatin to a closed state.
More specifically, Rtt109 would be recruited to sites of DNA damage through an
unknown mechanism, which would then recruit Esc4 through acetylation of an
Esc4 interacting protein. Esc4 would recruit HDACs, however, Rtt109 would
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maintain chromatin in the acetylated state until the initial damage signal was lost;
Rttl 09 would dissociate, the Esc4 associated HDACS would deacetylate
chromatin which would result in the dissociation of Esc4. A direct way to test this
hypothesis would be to determine histone acetylation was affected in the esc4A.
A subtle point of this model is that Esc4 would be displaced from
chromatin by the action of HDACs if Esc4 is being recruited to chromatin by
acetylated histones. Testing this idea, we could treat cells with an HDAC
inhibitor and monitor Esc4 localization over time after DNA damage. If this
treatment does increase the retention of Esc4 at chromatin after DNA damage, a
screen using the deletion collection may be fruitful to identify genes that
modulate Esc4 localization after DNA damage.
Finally, the reason that esc4A cells enter into S-phase precociously should
be further investigated. It is possible that Esc4p functions with the HDAC Rpd3p
and represses origin firing and thus prevents S-phase entry. We have generated
esc4Arpd3A double mutant strains to test this idea. If these genes function in the
same epistasis group, then we would expect no change in the total time that S-
phase entry is premature. Another protein involved in the DNA damage
response, rad53A, also enters S-phase precociously and the premature entry of
the rad53A into S-phase is thought to be due to a reduction in MCM complexes
at origins. To investigate if Esc4p plays a similar role as Rad53, we could
determine if there are reduced MCM complexes at replication origins in the
esc4A using Chip-CHIP. This would explain both the premature S-phase entry
and the extended DNA replication time.
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The DNA damage response in neurons is also an area of research
interest. Neurons seem to be especially sensitive to the effects of DNA damage.
Patients treated with chemotherapy or radiation often report cognitive defects
after treatment. MCPH1 is named because a frameshift mutation in MCPH1 has
been linked with human microcephaly. The phosphopeptide binding function of
MCPH1 and the role of MCPH1 in development has yet to be explored. It would
be interesting to generate a MCPH1 knock-in mouse that contained the
phosphopeptide binding mutation in order to determine if the mice would have
the microcephaly phenotype, in addition, identifying phosphospecific ligands that
are involved in development instead of the DNA damage response may lead to
the understanding of interesting biology.
It is expected that since MDC1 and MCPH1 have similar phosphopeptide
binding motifs that there must be some other factor regulating these two proteins
and how and when they interact with H2AX. There are many outstanding
questions in this area as well. For instance, which domain has a higher affinity for
H2AX? Do MCPH1 and MDC1 interact with H2AX at the same time, or does
MDC1 interact with H2AX first, and then MCPH1 is recruited later or visa versa.
Also, because MCPH1 has a role in development, finding the relevant ligand and
studying the role of the phosphopeptide activity in MCPH1 function in
development would be very interesting. In addition, a simple mass spectrometry
screen for MCPH1 interacting proteins and MDC1 interacting proteins after DNA
damage could yield some import insights in the regulation of these two proteins
during the DNA damage response.
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Additional experiments should be performed to examine the role of PTIP
in the mammalian DNA damage response. The first, and most obvious, is to
determine if the PTIP Cre/Lox knockout MEFs also exhibit a precocious S-phase
entry. It has already been shown that PTIP interacts with a histone methyl-
transferase; therefore we could monitor histone modifications before and after
DNA damage in PTIP-/- cells. In addition identifying new PTIP ligands is
definitely a set of experiments that can be performed using standard procedures
in the Yaffe lab by purifying recombinant PTIP BRCT domains from bacteria,
incubating the domains with damaged and undamaged mammalian cell lysates,
and eluting phosphospecific interacting proteins. As of yet, 53BP1 is the only
phosphospecific interactor for PTIP. It seems unlikely that PITP would have only
one ligand, as many phosphopeptide binding domains have multiple ligands.
Finally, determining if PTIP binds to acetylated lysines is also important. I
performed this experiment once with BRCT domains 3-6 and observed extremely
specific acetyl-lysine binding of the PTIP BRCT domains. Beyond PTIP,
screening the remaining BRCT domains for acetyl-lysine binding will be
important. I have performed this experiment with ECT2, BRCA1, MCPH1,
MDC1, NBS1, BARD1, BANK1, and RAD9 tandem BRCT domains. 53BP1 is an
important protein to screen for acetyl-lysine binding. The mechanism of
localization of 53BP1 to foci has been unclear, as there is evidence that the
Tudor domains of 53BP1 bind to histon H3meK79; however this modification is
not specifically localized to sites of DNA damage. Rather, the histone H3meK79
modification if found throughout the entire genome. It is possible that the
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combination of the Tudor domain binding to H3meK79 and the BRCT domain
binding to acetyl-lysine could mediate recruitment of 53BP1 in a DNA damage-
specific manner.
The relevance of histone modifications to the DNA damage response has
been established, yet how these modifications impact the DNA damage response
is not well understood. Studies performed in the Yaffe lab have focused on post-
translational modifications of proteins and the proteins that bind these
modifications. Screens to identify domains that bind to the histone modifications
generated after DNA damage should be performed. A more thorough
understanding of the histone code during DNA damage response and repair, and
how that code recruits protein domains can provide some important insights. In
particular, determining the proteins that are acetylated after DNA damage and
identifying the domains that bind these sites will provide a network-focused
perspective of DNA damage signaling. Beyond looking at acetylation, ubiquitin
modifications after DNA damage are also exciting. Generating antibodies for the
more unusual linkages such as the K6 and K63 polyubiquitin chains may help
identify proteins that are modified by ubiquitin after DNA damage. In addition,
identifying proteins that bind to these polyubiquitin chains is also important. For
instance, the identification of Rap80, a protein with a ubiquitin binding domain,
helped build a pathway between RNF8 modifying Histone H2A with ubiquitin,
which in turn recruits Rap80 and BRCA1.
Distinguishing between the potential transcriptional effects of histone
modifications and the actual effect these modifications may have on DNA repair
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will be important. This may require generating artificially tethered chromatin
modifying proteins or using drugs or temperature-sensitive alleles of chromatin
modifying proteins so that they can be inactivated in a fairly instantaneous
manner. This would ideally help separate the roles of these proteins in the DNA
damage response from their transcriptional role, as the transcriptional effects of
chromatin remodeling proteins is an important consideration in any study that
alters chromatin modifying/remodeling proteins.
Finally, exploring the role of the DNA damage response in cell cycle
continues to be an exciting region of research. The regulation between HR and
NHEJ is becoming more characterized, but is by no means mechanistically
defined. A bioinformatics screen for proteins with both CDK motifs and DNA
damage motifs may be a useful screen as it may output proteins that can sense
both the phase in the cell cycle and the DNA damage response.
Another area of research that continues to interest me is how DNA repair
and DNA damage signaling communicate. Which pathway is activated first?
Does repair often activate the DNA damage-signaling pathway or are some
lesions so routinely repaired that the DNA damage signaling pathway is not
activated at all? While DSB repair and signaling dominate the field, these lesions
are not necessarily relevant to the human endogenous DNA damage response,
and so the question becomes what happens under normal conditions in the cell?
Answers to these types of questions will transform our understanding of the
biology of the DNA damage response.
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SUMMARY
Histone variant H2AX phosphorylation in re-
sponse to DNA damage is the major signal
for recruitment of DNA-damage-response
proteins to regions of damaged chromatin.
Loss of H2AX causes radiosensitivity, ge-
nome instability, and DNA double-strand-
break repair defects, yet the mechan-
isms underlying these phenotypes remain
obscure Here, we demonstrate that mam-
malian MDCl/NFBD1 directly binds to
phospho-H2AX (yH2AX) by specifically
interacting with the phosphoepitope at
the yH2AX carboxyl terminus. Moreover,
through a combination of biochemical, cellt-
biological, and X-ray crystallographic ap-
proaches, we reveal the molecular details
oftheMD/NFBD1-yH2AX complex. These
data provide compelling evidence that the
MDCI/NFBD1 BRCT repeat domain is the
major mediator of yH2AX recognition fol-
lowing DNA damage. We further show that
MDC1/NFBD1-yH2AX complex formation
regulates H2AX phosphorylation and is
required for normal radloresistance and
efficient accumulation of DNA-damage-
response proteins on damaged chromatin.
Thus, binding of MDCl/NFBD1 to yH2AX
plays a central role in the mammalian re-
sponse to DNA damage.
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Mass specr ry revealed that  wo pryinent bands
at --250 kDa wet MDCI ,the two banos kly reresent
plice varis , the bands of •150 ka and -116 ki
were RAD50 and PARJi resperaety, and a somewt at
werer band of -Il% kW was NBS1. Wie the presence
of PARPT1 n the pit-downs ws not further analyzed, West-
em blat arases with antiboes against tuan I aid
memters oftthe lEt1 1  4 1AD5O SS IAttN( conle con-
trmred the exatence c these in the H2IZAX phosphtnc topeak
po-sdowns (FIe 15. By ccntxast, 538PL, BHICA, and
PTI•-I-C4i1 -domain contsal proteins that acc-aulate
am IRft and colocalze with yH2AX tWanre at at, 2003; PaulT
at al., 2000,: Shtz et atf., 2000w)--wre not erteey re-
trieved by tie yH2AX ospopeptide. Furhenwa•e, ATM,
L•A-PKc•, andEt NHEJ factor KuTMalso did n c associate
Cifically with the yH2AX pep~tde Weak associabon of
ATM with the H2AX phosopeptae was, hrwever, de-
tected in "t stserca at detergents in the wasting butler
data stown). This consistent wit our ea-tr inding
that AIM interacts directy wfIc NB6 (tF at al. 2005e 1
Tavi 1. TC Btnhng Mnwmvet of MDCI Md
WICAS BICT Domafw Mlth NUX Peptlde
SyThe Peopli
Cel: BDOT Domain Sequence K (PM)
"WC1 $ACT WT KKATOAS0Y we
KMTOApStEY 22
KKAPTOApSOEY 2*0
KAPSQG 4KATOApSCEY 2.3
KKAT4*gflYM NW
MOQI OOT KI' M KKT0eAS0Y so
WE irhicaten e lte bati dnane fra MDCI u C!? can-
couitntaws dat kdsst oIt 4M. P7 at AS OAnO ltagttro-
and that t••e mterac tn between AM arnd NS is weak in
the absem1e l DLWA and i s de l•t t ow datergen oon-
centtatios (Fa•ck et at,. 2100 You et al., 200s. logether
wit ou previous nrlng that te s•x•atin ot the MIN
cownpex wVt yH2AX depends on MDC1 (Laas aet at.
2004), t.ese rsads indicate that MDCW is the predotinan
yH2AX bding proton in n•rla extracts derived from cy-
Ciog tdnsmged hmar ails.
MD1 cI Otai s two phosphorspeclc proten brdirq
dorrsosn an iFHA dmein at its N termnur and a tandem
B1CT domain at its C terrnus. Howeýe, phOtvarp eptrie
pue-down exWperiments with bw-teaiy expressed GSt tu-
sions of thes regions stowed that arty the tandem BIC?
dre!i baund tightly and speo•aly to re yH2AX OftS-
hopeWctide (hgure 1C). Cnsetent wrth this, only wil-type
MDV I but rnot an MDC muiant tackng the SFCT dwoarnrs(A*CT) was retnieed trm nulear extracts o transfected
29X3 oes iTgure IDt. These resat tweby eastkis that
MDI i•teracts dreety with the yfH-VAX ph hopept
va Ais C-termirN sICT doTEirrs.
B isothermal Itration caloretry (•TC) rreasumemnts. we
estabshed that t-,e MDCI &iC0 reýgn bountx stoichomet-
icaly to a 10 residWe orpropeptide corre nirg&ýV to the
y H2AX C tminus ith an a#nlny ot 22 AM tfbiure 1E and
Tabe 1, simenarto pror•Ay charactered SIC T-atiosto-
Oeptide interactiors anke at atl., 2003 fbdquez at al.,
2003: Yu at at.. 2003• The lldtiion of 6 H2AX residues at
\'t xiion cur tcak-iar xt CX > rs cnr0 ci fa- .1AX critic c3 acvni crrn rn ia'j4r'cc U tahn 4cflgrtc cA ira tU \h' A a
anxnc wiii dam wstmcd 4rnit tM.
-tU TU t"P'q 3*w r'viri~iay in 'ivrt-ia ii*saiw WC? fRA ,r. > Ax i ,re rai"'r' hr- . ayw t,4 ta4 '&h& 'nn, C. W IQ' P14
iKn cc t- i-VAX p-c c arn Sir ' 'tNct tind wit ncnflnr HtJ cacciic. ýX 
.
C'g: r ~9~ XuOtcplt 1W X t5C1(orX tf)clii XX~lir}X~*, cit:r~s KkiiX~a pitt i·lCirfp) TSi m
KKtOZ44,OacA i-ta) crQXkt£ka-,Tflrxwvi. -4 4 42 xAflit izxsnoul' (*mt 5' -X 41W m29, I i " ,1504r' htih 1 WAiicrgcz't*n u m ,esn arirc cmncn a--rc a- <scibea ag-z- xrmamltc *ata mr - hfitmgitae tarry tin/ma.r
Ciii 121 1t23'z{ '23 1ece'ater 9lt 'ACd~W t qk inu; 1215
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BRCT: I . l
1-! -- _-ýýVt$V
GST WT K1936M
BRCT: --.. Noa
tDCI1
H2AX
S WT S136&139A Y142A
RgW 4. Consenred fResain wW the Tsndem BCT Domain and t Vwl tAX 0 Tee"mns Ae EAsem t" r tb lSt MOCI-7IzAXW AsaceIktoa d WCO1 tRI M IF Ftren
AW -av0cp i4*cur'w, r r 4 wct :dle muI? rutr: n us wa;r I ru sir nar rt ptom P t , *
W 1 Wocranv cntan awemwrt tE Sr xccseptit wdrg * E rrcgtr.s M/UG' kta rmirjn mintre aai sjf 1ti th r rok .TlWT Ev otrtmhlr mu? Ir, 'iX vvt3 *0A cfr rArr twlWC 135 #tersg: or ;ncartrrc Mt tyrp mrid -.ixtwtP \VCI Lacy w t Ianqtg t v tr '0 (S C lr truatr iC trmtsttctnd 20M cii3F an$ 4rpp t ir'o~i s1 l rtfr* t3 GI r t9l6,V vti3 { l4T .1 5 Ow: wsw' m-Ftvarr rrntfl tfuff IQAX
cott the phphos , and Arg933 contacts bott IF
neptde baicxx and the C-term cubtcate group.
Sqifcantty, rtation ot Argi9S to GIn  I1933 com-pleN AbdiWshd detectable ptOsO)pKpOa b"V irtdin by
the MDClI tie 1 n, M wQime uthtf te tewo aphospho-
serfetcorttng resiues ha a less cmac impact but
at? sijgtifa tanding thga.0re 4A). ihe pwalS
detects of the T "tit*V and K!i93% nxtr•ts can be ex-
roined by a sawew tc ontrbuticn at M b 1 phclioaer-
e-cntactng rec tites to the oversl Stfity e COrM-
Qift. Howeer, unliU the statei fior r thesct 1ACT1
domat the weak raidul phostapeaide binding actiVIty
otfto KIS93M tsAaM was treuttlnt oit to compariovey
Intif binding oft t-ilength t call MWCI to the yH2AX
o*h(pFOVW w (re 48). Consat wIth th MCI-
y-H2AX snteractn being importart tar MOC IRI- lrtison,
w" nou*t tNmuh transer tr•raec• stAes tat. wta
tutl-legt O1 fuIsed to CFP taorWmed 1RIf e~aN", the
1F1330 and K193AM oont-mutated derstives dO not
Whgre 4C).
Next, we d nefrtIed the allct of mutatigL t H2AX C
termarrs cnt WC1 I111 taomation Coradtent with preseous
reports, we kxrnd that tQAW p63 motse ertrAyir
titt fsast (  were defectie l~r MDCI t r tortro
iigure 40D Lee et ad, 2005M Stewt st at. 2003J However,
whif mintrocug a ge)IefrtC ftraoent caryVti the enite
H2AX transcrtoW ulit (Caleste at at, 2003b) osacu*d
theMDCI ltde~N fctý, o 2AK p53 MEFs, expraessio
ot a -2AX mutant which the two paW hoew ptor Se
reaises were cwinged toaa I St3&1•39W A did not. kftrWtrt-
tingy, antrod w cg no H2AX'l p63' ME HZAX mu-
tatas Mn whct t very C terminus wasaltored resmited in cal
Cclr 72 121$a-" '2!O l 2zon9s , 2t1 PAOt &trwenlrsc 1219
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+AA
YFP-IRCT fT' •
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H2AX 5 3 '
1.
C~z~yi~vlta~ - ~
iles w t erT y rsiy rntal H2AX phsOtshoryltaon and
yH2AX 1 tIformaan tion twinth veredects in MMI ac•-
rmurmtion. 1hu chagng the C-termnial T yr to Ala (YI 42A)
ed to a complete detet in MDCI f tF Iotnsatlr, whie ex-
Mensc of tiw H2AX C-terme&ali t by two Aa residues (I[AA)
signitcaniy rfeduced the sie and intensIty of MCI0 iuF
and creased poI•-rxidear MOCI staing (figure 40). To-'
gattIr, tese data show thaw t imulang MDCI Co H2A' X mn
ways that t the MCI -y*H2AX iteraction 'wads de-
flots in MDCIlt I~FF fTo n r •R .
Interactlon between MDCI and Zt.o2AX it Required
tle Effcent Accumuaton oM f O53BPI., NBSt. and-
PosaphorVlated ATM at Sites of Damaged ChMnrea
to establish whether the 4 1 -y2AX intection re•rts
tha' DD FItmators to r sof damaged dirmtin, we cre-
ated L2am col lines carr)ng staty integrated, tetracycue-
regulated expressin cassettes recting the exoreswon of
wid-type or KiS0A ruatant MDCI tanderm WCT ssivs
tias fused to yetow tuescant protein (V, P. As sIxain in
fio~ e A, and cona•Ient with pre••-,s ewrts • rg
at it, 2003, Xu and Stern 2003), efeton' of the
wd-type MDCI ETC reagon ptrevented H1Ff tormaisin by
MDCI, 538P1, N6S1, ad Sert9fl-ros ylaed ATM
4Atltaotivationtinvoliveisits austophoefhrytsiflor n a Sari t,
and this autophOSrsoated seces fost s if IaF; Bakieist
aid KaStan, 2D=3). By contrast, Mietn the K193M mutant
was overexpressed. MDC1, 53M1, NIS1. ard plospfo-
51981 AIM tfmned tMFF ina manner incsnguisnae fron
that in cots not expfressitng the Yf-BfT construct (0.e, in
nor'sfijced cels, Figure SA. comare top and bottome pan-
eta). CFre4presSanotthe 119330 mutantalso did notatfect
MDC 1 ,53W8P1, PS1 .and phcepho-S1981 ATMIii orrm -
ion (datart not lown). T the binding 0of t isolated MDC1
filET egon to HMl2AX prevets 111 formvatian by endo-
gewos MDCt and also blocks the accr laon of other
LXi factors at ses O DNA damage.
As a comlemnvsiy lroec to investgte t-e ipr-
tance of the MDCI-y2AX steracts, we exploited our
fading that H2AX p53- M s stably expressi tg e
H2AX Y1 42A Autant dse#o0d '2AX orcsprytsc and
VtIAX If0 tornstin Wut not MDC Ifl forr1W uici (Fig-
ie 4M). Cooststert wtr'h •a•Srious reports (Celeste a el.,
2002 Stewart et  at, 203;: Ward at al., 2X-•3;, we totnd that
MoC0, 38P'1, and NSi1 did nox trm detecitle ThIF in
H2AX p63 WPfs (Figure 58, top parel), whereas
they fomed nromlnay i I2AX Ip53' M-EFa ccrple-
mnted wath wild-type H2AX (Figure 5t, miidle pol" Sm-
ry(, the Serl981 -autopWsc "1seile ATM formed toc in
an H'2AX-dacnden fashi on 5Igue . Strongty, w"'i'
t'Ax W00 were detected by antiodaes i t2AX ' p53
MEW s complemented with the YA42A mutant, no ItrF f W
MDCI, 53SPI. cr NSt wre cobserved in such cells Fig-
te 5tB. .ottom pare!. hthermore, while ATM auphcos-
phryltabn stia occired in '24AX p53 MiEs ard in
H2AX " 63 ' MEis comemented w th the Y142A mu-
tant of I2AX (data not shon) p•) o phOprlated ATM did not
tam faci n such Ct& B instead, Meak c-nuOler ataini oV
p~hoscno-Sei~BI AIM was moseved (Figare 58, bottom
paort. thus, qimtatbor' H2AX to a tran that can stil be
ph'osrosated but no klonger binds MDCI abrogates illF
tfamatin by at 001 factors tids.
T ,e above results estabith the MD= 1-yH2AX inteaction
as a • al determrnant for fIF tormatn. This is pertps
rmst simply exaimed ttrhIr hMN carieX, wNW interacts
C1retty with MDCI Gokidbe'g aL, 200). Fur••t•more, as
f to Wat by hosphW lated ATM repes intact•is
between t ard the NfIS C terinuts WFaik at at, 2005),
an inablty to somr MRN RF' presusnay causes defective
phosho-ATM Too in elle datupted for the MC1-yH2AX
interactiors. For 534Pt, however. the situation is l(ety to
be more corOx as ri ~ ng to cOatri at 0DS sites
is t'otq to be diected by tintone methylation (Huyen
at at, 2004). On the other hand, efilcint 538Pi accumiua-
tion at sites ot DSBis also reqUtres yH2AX (Ceste et al..
2002; Ward et at, 200) ad a turctiona MCI I --d2AX in-
tractiu y tiNs studyt indcaWt that WrU ng to metylamted
histoes sr not sufent ori 538P1 IHF famriescn. Vs inter-
pretatron a consistent wah a recent report entsnfyrig MOC1
asa key 4streat determiant of thedynarr asssmbiy and
Figun S Dke atraston betwe MDte WCI WnW 92AX Is Required for 3SPI, 4851, aend srspbh-APJT PI Fomalios an flor
Noma Rhdorouestarce but Nt Or Actlvanion of tw intrra-S Phase Checkpoint
W tK*18' '4U'J was .fyr i 'Al. it na'yr<~ n* 'us * sk ,n t~ t,V arek >'vtsfltess*,ays e .4s ts,5vni(to
ltfttiw:tyrcYl' t.) e21c a g :se ddtt ro m V VItiC'osar dar
ThlsnaasrlAJWIl, 228Ff P MS and crcspre S' AIM It br7tba 32 'mntnf IW Gg FtAW ot P at tim wdtQM ;*3 \**sdI ' 1y¶As ,st wlI f~ s WI sssý' ag 124 ;,r,4 IM I Lt-;,fl- 07' 'C A tp r pt-fl .%'s VZA tstr
ly I ý'J Ita tfw A , :1-- LF - rxk. f " y,. 4"", rutsw efO v-, f~e- A- Owt
'C' art g r ceroperaco ofEINAL\tX W4C' 4emrws rh zenetjeshNirsfl cotrtiima c Cf Ad0 9" 'r *C 'urrr crcinc a,'ura.com Sir
<.Asystrwi*er f'*'sfl D " t-~'t s sr nsls4 *wMsusv' so'sj5es ag o~I s in sstflaft Srw i delfe es Mris*p*M1AZ I ssnfeliss
. na fl5X tsWo nts a kstre s cr V 543A "'Xtgtal w A tve YIrs LWC es Irict pfl wriýrwfIWftl * 'saw't etrwetel a 7 IJws11 1
;ut C r mj rol te ' Ia' pu z, sforQ tc n , prea Wexgat orzrccsa' t we iý YH' '!C knce r'ss'sa~~~ry~~~ytsnyslsl'XelO Irnfn 1t4ttc st M. * d Ir an s'" ' Ote n 25 4101 _P 4lkst Hcskmr Isv ZUtisgrsh * snsrsua> t ats C' fiTdo'wrse ro e) vt'sfls #ra't so'ees; sQ 7 eeqcsecsfs*tT raesuawtfl~WVwfl R^t emsy
alfera 'nC4 It ' grkss sradtzlez Ora'l 'Tnoo Nfex34 40tot isaa'i0 rs sslei coz'cf iiossi cattf LA w't s'e Ms t aodr-d Is silty
'sstnin 5<J sy IQ leEaterssslieetto4# sss'ecsxtrws ¼%tM IO s'dltArstonts swrsphab w'e itis' ssweasssestetl< says~os~s2on verstle it is
WC' S oretecre Wy 9QM lys'4¶s C4%A trwtt'iss Met 's'eakron atwo trantrots' witees 'J.t' la'csfs s:itA :r',tr trep ia uos'orna costra
nTIKA b'n ites's Us n'sss 'ss f*etvs fWIW ' sios tets> wet "'taostS' r(ate" ats'w s less' sisissi sisss ttWssc''sil n cisteen nigsi
COii 123. '?' t?12Ii tDecnvtxsr9 51XtU 'T2I2Xst-taer nsc 1221
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Figure Ik MDCI Conntros y-fZAX Maintenance bty Two Synergistic Meclhaintiss
A' WA I' MxAve An: 2' '.. U½ r Rw "twt a 41'W~x p ph, he v nee tr artw a s
Cd; Sim fl~r'c ?9gfh sA of 'AX hi s', "'stxua: rtcd' .trc a, c' un
'IA #1 tth"'tt Vg'I'y Ietio~mw l.gI Axp' ''A' 'lI tm mitrc edwth '1." T3C-P: w. oflt.he. rtctk )c 4 '4.
lemzarL2r.M N'cI:' t J.Ac 1', a C'dW & :a rrt"' i Mara a: fOr Ž'r- 3i Mitylhn tsaci' nt af al' d sn t' t' *r'tc's catp'xyin
It fAPI) 1 yv: I t'lttj
A"N .cthrc..2 ci 'Sc tog '~ jaterl. '.t'5t r citxk 'ee .c"I' I" ""A.' .1ic IC'4'#I' P'. 21 'ic" 'rAtttlcat"
prtefl 1d not jF-'ute 68 NAlso ssa¶c.irg a role fi KMIXY
tin regdtg vHrAX dEchossvrva'tcn. wie fcerC tfiat
U2US :cas exprsssrq IN.i O1CI ta ee-m BFC aroerk
Y4P tsc d'SpkyeO hqg't levels of -A2AX Ccloseoito•
tr- mancotr cals I' qte 583& Furttencre o3n'dea'
txvckqtad y'A2AX stairfrg was genetalYf ctsrved it)
Y'6? i-C l-Critiessnig cels, at'te' Irfe'sty d ths sheflfhj
ccRetaled wit tI he extent ci 4 P-Brift oersgr~' esscn (
We SSQ. Althtugp tehe )u chris V y r2AX ieval in
'aImemman cetS is fat yet ardfsstotz a-d tilet ptsphutase
regonsble tof dcsstcsrtcr'ytic oc &39 has et -o t e
idetntiied, these fiiri'gs sugges hat trone mecharmins br
wirch MUGI regUates fr2AX nkrItenance rAtohes 'ts
catrl of vHZAX dedtccortan.
It has ecently beer demCt-ated tha91t M1' .ndergcres
a cynamc exchange bewtwe trL CYittoti Mrr h e p tIe
snes of LYSs and the racirbring iucteca s', with tne
fian 'cadence :ti7e at the deinje sices oi c ay 6 s L ut'Ues
m- at, 2JYI. Such a rapi, excha-ge is Ikaey to xraciee4 re-
toated at occ taW cMhsphorvtn cycles Cof H2AX
1n Camagled-c*'.~atn regrs TIhus. arcite' way that
MUXl rm1 n t'ece yI2AX nat-na-rtce s by contcing
A IM actity l ar  et a., 20Xi. hcwmever, wheen we ans'
lyied cat to a' lr Ilktl treatment, MUGC Iceticon f d i)no
dscimc tice rfect .r ATM Set I tiow s orp oatvn ci the
dinhcrlaton stale of severa known ATM targelt prctair
iK2c. NLIS SMtA, and pS3). dcabsrg traT MEXU de-
pdaton toes not rriai ATIM actvipy pa'r se( e SSA; Net"
eYhetess, arfc co&Istsfle with data otainted in oats overex
ressing the MDCw BIC rH on. MDCI deoeion led to
ocrsistet ctdect ts VFt tr11 t io'nrsao Dy pt'kspho-Ser1981
AIM 'rýoe 60,; t-s shoes a fiixte pcoalaten or cas
contarq ether a LacZ shiiA c an Mr sW WINA, and
ATM pl4ih'cs- ver1981 fl:a exist rt the crr aut not the
Satte- these tr s raised the ýasIbitl that MDC1 rnppt
Inuaene H2Ax plosvp ytbon by 'elarig active AIM
rciAC'9 LA$ C%:i t'l 'ftCilt'4l') A? L~ '?'f3 Ami'6is~ W 1223
136
rrv~tnn ;~r cr ~ p q ~iu , 9 V ~i e~ ~' ~"
(and pertws also XNAr Ft dafYneged-cromatvn regins.
Sirce NVC1 i5 vaJ for the acwunmIatUs odactive ATM or
dareged chrcmatin, t is awcfaoble that the local OcIen-
itratia of active ATM at sites darmage mediate by MDC
may stit the equiktfkant 0f tAX apho trylatirVdephos-
pfriottor toward pWvspterMstlOt Ftos a fodldd to ax-
pier the rel tue l-ss io •• os.hePyatler upco lon
oa theMDCt-yH2AX interwtio, we reascxrE thatt conmnal
AIM arc DNA-I activty would be reteda for tsraiMntaiog
nom '2AX phosphor$Scn. ITo test ths we t•ated cots
wit 0R, incubated them for 10 msr to allow MAX ptlwsor-
yatior ;a athen trated or mock treated them wit anal-
moecue tttors of ATM and DNA-PKcs. Whie #2AXM
ptcphwhytatson was rrewtar•ed r sreral horts in the
mock-treated cells. AI was rapkdy lost in the AWrt -treated
cels (Figure 60 nftar results were cta id with ott
IKK targets such as CK2 and S ; J. , personal
crmnncatij. Ts  eveas that continued PiKK actily
is e e tafor k mat y•MAX rltereace and suggests
that MDCI-imadsated PIKKC accumulatitn romtes notrial
yH2AX nwrteircoe. n uction , carralsor at H2AX
^42" totales i wictt-ty e rid YV42A.-ice-
mented 2AX ' p iEFs that expressed comparable
araunts da total H2AX rfeeLted sgiftcanly lowrs Mtoels ot
H2AX pIOepharynytlat in Y'42A-cvon~ reted Clts (Fig-
ure -55). Based on a these ts, we suggest that MDOt
cortbutes to nritl H2AX p'prytlon after IR botxi
by protectN yM2AX f pho sphaasesnd by prtrting
H2.AX posphD yatW throY Its m riatin o• te Ment•n
ot ac•wA Kln and pOasby also DNA-• K in daged-.cro
rmalt regiom It tas a tar rot bee posesie to distarg
betweenr the relavecotrib" t Vn at,these m•e ¶astis be-
care dSrtio atof the MDI -yH2AX anterct of deple-
tia of edognous MDC I tetere wAh both processes.
We have presented och•err , bckls , anid sltruc• u
eidence indating that MCCI is the predoinst y2AX
rCogat rfxlo• st h igh o artes. irstly, we dmomn-
strate Irat the • CT tander n taw of MU'C interats
tigft and Ispeicaly wth m paptie tpesen the
yH2AX C ternus, and that bnding a abscuely dependent
on ptatsaaoR n 04 Ser-39, the ATM target sAte Second,
ma* X-ray strcture cd the MOCt -yH-2AX corrle raves
that the RCT-dOman bindng Clet is IaIitey talared to
recogrize the Y iX mom? ad shov tow Mte unusual-
and poasib urie-'ominty the Serl3•M l•l4 P0CKK
ptsphcyteatinn se to 10 H2AX C tenarsus is detected.
FIa-wly, we now trat the major ufmCioIn c INs inrteraction
is t promote accm•s•tilt. o •n• proloned Inteacto dat0DD tactlors in daaged-Cinroatin 'e1ons, a process tat
appears to be a tresenia  t ard accurate D repair
butriot tar dnecoint activata. 1 ogetier, o'data demo-
strate dearion ws sreterance o the drec interaction between
MOC1 and y2AX and hae importart scarec astic, bioog'
ir and e iOnary imptatonis tfr otur uriea n ct
DNA-darnmage-irtiated evnts T m coontec af ctroratin.
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Figure A-2-1: 10cm dishes of 50% confluent U-20S cells were cotransfected with
a PTIP hairpin and either GFP vector alone or GFP PTIP vector. Cell lethality
was observed in the PTIP shRNA transfected cells that did not receive a plasmid
that rescued PTIP expression. Hairpin A, which was designed to the 5'UTR of
PTIP, cotransfected with the PTIP hairpin, had defects in cell viability. HairpinA
cotransfected with GFP-PTIP looked nearly identical to the plate that received
the luciferase hairpin. Therefore, we conclude that the PTIP shRNA causes
viability defects that can be rescued by GFP-PTIP.
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Figure A-2-2: 10cm dishes of 50% confluent U-20S cells were cotransfected with
a PTIP oligo (o2 or R) or control hairpins (GFP,or MK2). The sequence of the
oligos are as follows: o2: AAGGUAACUCCAGAAUUGAdTdT
R: UGCACUAGCCUCACACAUdTdT
MK2: UGACCAUGACCGAGUUUAUdTdT
GFP: UCCCGGCUAUGCGCAGGAGdTdT
The cells were transfected and then collected at the indicated timepoint. For the
96hr timepoint, the cells were retransfected at 48hrs. Although there was a
partial knockdown of PTIP, we did not observe a cell viability defect.
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Figure A-2-3: 10cm dishes of 50% confluent U-20S cells were infected with
lentivirus with either a control (lucif) hairpin or shRNA2 (refer to table 1 for the
sequence). Cells were selected with puromycin for 3 days and then collected,
lysed and subject to Western blot. Using affinity purified PTIP antibody that we
generated, we observed loss of a band that corresponded to the appropriate
molecular weight for PTIP. We noted a band of very close molecular weight that
was not knocked down.
Having generated a potential PTIP knock-down cell line, we wanted to determine
if PTIP had a role in the DNA damage checkpoint, in particular p53
phosphorylation. We found that Ser15 phosphorylation was not affected in the
PTIP knockdown cell line (labeled 2) relative to the luciferase control (L) after
10Gy of IR.
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